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A B S T R A C T
Background
In the search for better surgical treatment of chronic low-back pain (LBP) in the presence of disc degeneration, total disc replacement
has received increasing attention in recent years. A possible advantage of total disc replacement compared with fusion is maintained
mobility at the operated level, which has been suggested to reduce the chance of adjacent segment degeneration.
Objectives
The aim of this systematic review was to assess the effect of total disc replacement for chronic low-back pain in the presence of lumbar
disc degeneration compared with other treatment options in terms of patient-centred improvement, motion preservation and adjacent
segment degeneration.
Search methods
A comprehensive search in Cochrane Back Review Group (CBRG) trials register, CENTRAL, MEDLINE, EMBASE, BIOSIS, ISI,
and the FDA register was conducted. We also checked the reference lists and performed citation tracking of included studies.
Selection criteria
We included randomised controlled trials (RCTs) comparing total disc replacement with any other intervention for degenerative disc
disease.
Data collection and analysis
We assessed risk of bias per study using the criteria of the CBRG. Quality of evidence was graded according to the GRADE approach.
Two review authors independently selected studies and assessed risk of bias of the studies. Results and upper bounds of confidence
intervals were compared against predefined clinically relevant differences.
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Main results
We included 40 publications, describing seven unique RCT’s. The follow-up of the studies was 24 months, with only one extended
to five years. Five studies had a low risk of bias, although there is a risk of bias in the included studies due to sponsoring and absence
of any kind of blinding. One study compared disc replacement against rehabilitation and found a statistically significant advantage in
favour of surgery, which, however, did not reach the predefined threshold for clinical relevance. Six studies compared disc replacement
against fusion and found that the mean improvement in VAS back pain was 5.2 mm (of 100 mm) higher (two studies, 676 patients;
95% confidence interval (CI) 0.18 to 10.26) with a low quality of evidence while from the same studies leg pain showed no difference.
The improvement of Oswestry score at 24 months in the disc replacement group was 4.27 points more than in the fusion group (five
studies; 1207 patients; 95% CI 1.85 to 6.68) with a low quality of evidence. Both upper bounds of the confidence intervals for VAS
back pain and Oswestry score were below the predefined clinically relevant difference. Choice of control group (circumferential or
anterior fusion) did not appear to result in different outcomes.
Authors’ conclusions
Although statistically significant, the differences between disc replacement and conventional fusion surgery for degenerative disc disease
were not beyond the generally accepted clinical important differences with respect to short-term pain relief, disability and Quality of
Life. Moreover, these analyses only represent a highly selected population. The primary goal of prevention of adjacent level disease and
facet joint degeneration by using total disc replacement, as noted by the manufacturers and distributors, was not properly assessed and
not a research question at all. Unfortunately, evidence from observational studies could not be used because of the high risk of bias,
while these could have improved external validity assessment of complications in less selected patient groups. Non-randomised studies
should however be very clear about patient selection and should incorporate independent, blinded outcome assessment, which was not
the case in the excluded studies. Therefore, because we believe that harm and complications may occur after years, we believe that the
spine surgery community should be prudent about adopting this technology on a large scale, despite the fact that total disc replacement
seems to be effective in treating low-back pain in selected patients, and in the short term is at least equivalent to fusion surgery.
P L A I N L A N G U A G E S U M M A R Y
Total disc replacement for chronic low-back pain
Artificial joints have had a remarkable impact in reducing pain and improving function in the knee and hip. But what about joint
replacement in the spine? This systematic review set out to determine how total disc replacement compares with other treatments for
chronic low-back pain in randomised controlled trials.
The disc is a strong but flexible structure that cushions and separates the bony vertebrae of the spine. Disc degeneration is a nearly
universal feature of the aging process. Though there are many theories about the causes of low-back pain, chronic symptoms are often
attributed to disc degeneration. So when patients do not improve after nonsurgical care, they sometimes consider surgery to remove a
degenerated disc.
The traditional surgical approach in this area is spinal fusion, which involves removing all or part of a degenerated disc and joining
the vertebrae above and below it. Previous reviews suggest that fusion surgery can lead to moderate pain relief and modest gains in
function. It appears to be superior to traditional physical therapy-but no better than an intensive rehabilitation program.
An alternative surgical approach is total disc replacement, which involves removing the disc and replacing it with an artificial implant
made out of metal and plastic.
We identified seven randomised trials-involving a total of 1474 patients. Only one study compared total disc replacement with
nonsurgical treatment, suggesting that surgery resulted in slightly better outcomes than intensive rehabilitation. But this did not translate
into a clinically significant advantage that would make a major difference in patients’ lives.
Six randomised trials compared disc replacement with spinal fusion surgery. Most of these studies had a high potential for bias, raising
the possibility that theymight not have provided a fair test of the treatments under study. These trials found that patients who underwent
total disc replacement had slightly better outcomes in terms of back pain and function than those who had fusion surgery. But again
the differences did not appear clinically significant.
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The review could not find evidence of any other benefits of total disc replacement, and the studies provided no insights on the long-
term risks associated with it. Given the gaps in the evidence, the review concluded that the spine surgery community should be prudent
about adopting this technology on a large scale.
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B A C K G R O U N D
In the search for better surgical treatment of chronic low-back
pain, total disc replacement has received increasing attention in
recent years, especially at meetings of experts in this field and in
non-peer-reviewed publications. In 2003, our group performed a
systematic review on total disc replacement (de Kleuver 2003), but
at that time, there were no randomised controlled trials. Since we
published our findings, two more reviews with meta-analyses have
been published by Yajun 2010 including five randomised studies
and Van den Eerenbeemt 2010 including three randomised trials
and 16 cohort studies. In addition, three studies were identified
in the review on spondylosis by Gibson and Waddell (Gibson
2005; Gibson 2005a). Recently, additional trials have come to our
attention, creating the necessity to update the previous review with
this new evidence. In this review, we will convey the rationale for
total disc replacement, present the results of a systematic review
of the literature and attempt to summarise the findings on the
current status of total disc replacement devices.
Description of the condition
Chronic low-back pain is believed to have a multifactorial origin
of somatic pain sources, accompanied by psychogenic and social
aspects. A degenerating intervertebral disc is frequently incrimi-
nated as the most important somatic pain source in the lumbar
spine (Coppes 1997; Kuslich 1991; Nachemson 1996). Degen-
eration or repetitive straining of the facet joints, two supporting
joints, one at each side, at the back of the vertebral body, also has
frequently been depicted as an important contributing source of
pain (Ashton 1992; Cavanaugh 1996). The only available conven-
tional surgical treatment to prevent further deterioration is surgi-
cally fusing the two vertebral bodies, i.e. spinal fusion, spondy-
lodesis or arthrodesis. However, the clinical outcomes of this pro-
cedure are variable, leading to continuing controversy about which
patients might benefit from the procedure. The dispute is further
strengthened by the difficulty to properly diagnose the disc as the
source of pain. One prospective randomised trial showed signif-
icantly better clinical outcomes of fusion in comparison to non-
operative treatment (Fritzell 2001). A large literature survey com-
prising 5600 patients (Boos 1997) reported a “satisfactory out-
come” in 65% to 87% of the patients after a fusion, with fusions
of only one motion segment having better results compared with
fusions of multiple segments. However, as in other fields of or-
thopaedic surgery, fusion is generally not considered the optimal
solution to treat degenerative disease, due to the increased stresses
and subsequent degeneration at the adjacent joints.
Description of the intervention
The development of artificial joint prostheses has almost obviated
the need for fusion of the painfully and degenerated major pe-
ripheral joints. Similarly, in the lumbosacral spine, research has
concentrated on the development of mobile intervertebral artifi-
cial joints to retain motion and thereby possibly avoid the dis-
advantages of fusion. These disc prostheses are positioned ante-
riorly between the vertebral bodies, the two posterior facet joints
are generally not replaced or removed. The first disc arthroplasty
model, based on a steel ball, was described by Fernstrom 1966,
but quickly abandoned due to poor outcome.
There are currently several replacements for the entire interverte-
bral disc on the market, two of which, the Charité and Prodisc
L, are approved by the FDA. The Charité (DePuy Spine, John-
son&Johnson (DePuy 2009)) has been available since 1987 and
was previously named Link SB Charité, developed by Schelnack
andBüttner-Janz (Buttner-Janz 1987;David 2007; Lemaire 2005;
Putzier 2006; Ross 2007). The Prodisc L (Synthes Spine (Kafer
2008; Synthes Spine 2009)), previously known as the ProDisc II
(Bertagnoli 2005; Chung 2006; Delamarter 2005; Siepe 2006;
Tropiano 2005) has been available since 1990. Other devices that
are in the investigational stage are the Maverick (Medtronic, So-
famorDanek (Erkan 2009; LeHuec 2005)), the Flexicore (Stryker
Spine), Activ-L (Aesculap (Ha 2009)), Nubac (Pioneer Surgical
Technology (Alpizar-Aguirre 2008; Pioneer 2009a)), and Mo-
bidisc (LDRMedical, Cedex 9 (LDR 2009)). Some devices appear
to have been discontinued through market acquisitions, such as
the Acroflex (AcroMed, purchased by DepPuy (Fraser 2004)).
The devices differ in mobility and other design aspects. Charité
has the most extensive (least constrained) movement possibilities,
ProDisc, Mobidisc and Maverick have more constraints and Flex-
icore has the least movement. Charité, Pro-disc and Mobidisc de-
vices have low friction sliding surfaces, somewhat like a ball and
socket joint, consisting of metal endplates with a polyethylene
spacer. They are marketed as being developed from the successful
total hip and knee arthroplasty materials. The Maverick and Flex-
icore are metal on metal implants. The metal endplates are meant
to fuse to the vertebral endplates, much as the cup attaches to the
pelvic bone in uncemented total hip arthroplasty. Supplementary
fixation is provided on the SB Charité III by six teeth on each end-
plate, and on the Prodisc and Mobidisc by a fin on each endplate,
which is sunk into the adjacent vertebral bodies.
How the intervention might work
A possible advantage of total disc replacement is maintained mo-
bility at the operated level, thus preventing adjacent segment de-
generation. Leivseth 2006 evaluated ProDisc II and found de-
creased mobility at the surgical level. SariAli 2006 found normal
kinematics with SB Charité prostheses, but only for one-level pro-
cedures. Huang 2006 found increased adjacent segment mobil-
ity for cases with decreased mobility at the surgical level. In con-
clusion, in a literature review on adjacent segment degeneration,
Harrop 2008 showed more adjacent segment degeneration after
fusion procedures than after total disc replacement, but the stud-
ies supporting this were of low quality. Using a computer model,
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Chen 2009 predicts an increased instability at the surgical level,
but not at the adjacent levels. In yet another computer model,
Zander 2009 predicts decreased mobility of the segment, but no
influence on adjacent segments. In conclusion, most short-term
studies confirm preservation of motion to some degree and there
are indications for less radiological degeneration of the adjacent
segments when disc prosthesis are compared with spinal fusion.
Possible disadvantages of the intervention
At the operated level, Park 2008 found progression of degenera-
tion in the facet joints with ProDisc II and Rousseau 2006 showed
increased facet joint loading in human cadavers. Goel 2005 and
Rohlmann 2009 both predict an increase in facet joint loading.
Thismight be present, especially in constraineddevices (Moumene
2007). Rundell 2008 predicts from another computer model that
this increase can be limited by posterior placement of the disc re-
placement in the intervertebral space. In a computer-aided design
(CAD) model, Chung 2009 found that when constrained devices
are used, the loading on the facet joints increases.
As total disc replacement is a relatively new procedure with lim-
ited evidence, salvage options such as conversion to a fusion are
important factors when deciding in favour of treatment with to-
tal disc replacement. This is of major concern in these patients
as revisions through the anterior approach carry large risks. Punt
2008 shows that removal of the damaged disc, with anterior and
posterior fusion gives better outcomes than posterior fusion alone
in salvage procedures. Complications following removal have been
identified (de Maat 2009), and indeed salvage procedures are be-
ing investigated (Cunningham 2009). In a literature review, Patel
2008 points to the need for proper patient selection for initial disc
replacement to avoid revision.
Why it is important to do this review
Replacing an intervertebral disc in patients with chronic low-back
pain with a total disc replacement raises the following questions,
which need to be answered before large-scale implementation can
be accepted.
1. How do the clinical results compare to fusion, the only
surgical “gold standard” available?
2. How do the clinical results compare to other treatment
options?
3. What are the radiologic results with regards to loosening,
subsidence (slippage) of the implant into the vertebral bodies,
and wear?
4. Does the motion segment retain its mobility? And if it does,
do these motions resemble a normal motion segment?
5. Can the total disc replacement reduce the incidence of
adjacent segment degeneration compared to fusion?
6. What is the incidence of facet joint degeneration at the
operated level?
7. How does the perioperative complication rate compare to
fusion operations?
8. Is there an acceptable and safe salvage procedure in case of
failure?
In an attempt to answer these questions we performed this system-
atic literature review. Question 1 and 2 were the primary goals,
while the other questions were of secondary interest.
O B J E C T I V E S
The aim of this review was to assess the effect of total disc replace-
ment for lumbar degenerative disc disease compared with fusion
or other treatment options.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Primary studies for the review were randomised controlled trials
(RCTs).
Types of participants
We included studies that involved patients scheduled for surgery
for chronic (lasting longer than 12 weeks) degenerative disc dis-
ease. We did not apply exclusion criteria for age or gender of the
populations, or type, location or duration of symptoms.
Types of interventions
The interventions evaluated in the trials were total disc replace-
ment compared with any other treatment for lumbar degenerative
disc disease.
Types of outcome measures
The required outcome parameters in the studies were clinical or
functional. The primary outcome variable of our review was pain.
Below is an indication of the anticipated outcome measures, but
we made no exclusions on the type of outcome measure. Where
outcome measures were composite, we analysed item scores as far
as appropriate and possible, but analyses were also performed at
the composite level. The minimal required duration of follow-up
was six months.
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Primary outcomes
Patient-centred outcomes were of primary interest in this review.
Short-term follow-up was defined as immediately postoperative
to five years, long-term follow-up was defined as five years and
longer. The following outcomes were prospectively included:
• Symptoms
◦ Pain
◦ Pain medication usage
• Overall improvement
• Patient Satisfaction
• Back-specific functional status
◦ Oswestry
◦ Roland-Morris
• Well being, quality of life
◦ SF-36
◦ SF-12
◦ Euro-QOL
◦ Specific disability questionnaires
⋄ Daily activity
⋄ Return to work
Secondary outcomes
• Motion segment mobility
• General complications
◦ Death
◦ Hospitalisation
• General perioperative complications
◦ Thrombo-embolic complications
◦ Bleeding
• Surgical re-intervention
• Treatment specific complications
◦ Adjacent segment degeneration
◦ Facet joint degeneration at the operated level
◦ Donor site pain (if appropriate)
◦ Radiologic findings:
⋄ Loosening (In total hip arthroplasty radiologic
loosening is recognised as a precursor of clinical loosening)
⋄ Subsidence of the implant into the vertebral
bodies
⋄ Polyethylene wear
Search methods for identification of studies
Electronic searches
The following databases were electronically searched up to 22 De-
cember 2011:
• the Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library)
• CBRG trials register
• MEDLINE (from 1966)
• EMBASE (from 1980)
• BIOSIS (from 2004)
Search strings for MEDLINE, EMBASE and ISI are given in
Appendix 1 and are adapted for the additional databases. A sensi-
tive search was performed because terminology in the field of total
disc replacement is not yet standardised. During the search, no
restriction was made with regard to language or date. The search
was performed by the Cochrane Back Review Group (CBRG) Tri-
als Search Co-ordinator (RC).
Searching other resources
We searched the FDA register and we contacted experts in the
field. References and citation tracking results of selected articles
were included in the search. We also searched ClinicalTrials.gov
up to 22 December 2011 for ongoing or completed trials.
Data collection and analysis
Selection of studies
Two review authors (WJ, AT) independently selected the articles
from the list of identified references. Consensus was sought, but
when no consensus could be reached, a third review author (MK)
was consulted. If relevance could not be excluded on the basis of
the abstract, we retrieved the complete article. The final decision
on inclusion was made upon review of the full text. Studies were
selected when the Criteria for considering studies for this review
weremet and the study was published in a peer-reviewed journal as
a full article, excluding grey literature and conference proceedings.
Data extraction and management
Data were extracted onto separate, pre-developed forms. From
each study, we gathered basic information concerning authors (af-
filiation, sponsoring), methods (study design, sample size), pa-
tients (selection criteria and diagnoses, pain location, age, gen-
der), treatments (implant models, constraints, materials, levels in-
volved), control treatments (non-surgical versus surgical, fusion
versus non-fusion, anterior column versus posterior or circum-
ferential), and outcome variables with results. One review author
(WJ) extracted the data.
Assessment of risk of bias in included studies
Two review authors (WJ, NvdG) independently assessed the risk
of bias of the selected articles. Again, consensus was sought, but
if necessary, a third review author was consulted (MK). Risk of
bias of RCTs was assessed with the 12 criteria recommended by
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the Cochrane Back Review Group (Furlan 2009). Criteria and
operationalisation are given in Appendix 2. The items were scored
as ‘low risk’, ‘high risk’, or ‘unclear risk’. We categorised studies as
having a “low risk of bias” when at least six of the 12 criteria were
met and the study had no serious methodological flaws. Examples
of serious methodological flaws are invalidating extensive loss to
follow-up (> 20% for the whole study) or invalid trial stop after
interim analysis.
Measures of treatment effect
For dichotomous outcomes, we calculated odds ratios (OR). For
continuous outcomes, we calculated the mean difference (MD).
For each outcome, a 95% confidence interval (95% CI) was com-
puted. A random-effects meta-analysis was used for all analyses.
Clinical relevance was assessed with the five questions as recom-
mended by Furlan 2009 (see Appendix 3). We evaluated clinically
important changes using the guideline given by Ostelo 2008. The
minimal clinically important difference of the primary outcome
measurements (i.e. functional disability, perceived recovery and
leg pain) was defined as a 30% improvement from baseline. This
corresponds tomean difference of 15 for the Visual Analogue scale
(VAS) (0-100), 2 of the Numerical rating Scale (0-10), 5 of the
Roland Disability Questionnaire (0-24), 10 of the Oswestry Dis-
ability Questionnaire (0-100) and 20 for the Quebec Back Pain
Disability Questionnaire (0-100). In case of absence of a clinical
relevant point estimate difference, we also evaluated whether the
upper bound of the 95% CI was smaller than this difference.
If available, the analyses were performed on improvements of out-
comes as these account for possible baseline differences of the spec-
ified outcome between and within the studies. We evaluated the
primary outcomes at the longest follow-up term available, in this
case 24 months.
Unit of analysis issues
The unit of analysis was the patient, regardless of the number
of disc arthroplasties that were performed. If allowed by the pre-
sented data, subgroup analysis was planned for one- and two-level
surgeries.
Dealing with missing data
We contacted the principle investigators of included trials by email
with a request for clarifications about items with an unclear or
high risk of bias. If responses were received, the two review authors
responsible for the ’Risk of bias’ assessment again met to discuss
the impact of the clarifications on the ’Risk of bias’ assessment
and made corrections accordingly. Missing clinical data in trials
were accepted when this was less than 20%, otherwise, the trial
was excluded from the specific analysis of the outcome parameters
and follow-up time points where missing data exceeded this re-
quirement. Missing information about parameter variability was
estimated from ranges if provided or estimated from comparable
trials.
Secondary publications of those studies with single-centre results
were not used for analysis as this can be regarded as incomplete
data reporting. We excluded from the analysis further secondary
publications frommultiple centres where the included sample rep-
resented less than 80% of the initial randomised sample.
Assessment of heterogeneity
Heterogeneity between studies was first assessed clinically and then
statistically. Clinical heterogeneity was evaluated for study design
(allocation concealment, outcome assessor blinding, patient blind-
ing), patient characteristics (pain location, levels involved, age,
gender), device design (constraint,material), and control interven-
tion (non-surgical versus surgical, fusion versus non-fusion, ante-
rior column versus posterior or circumferential) variability. When
studies were judged to be clinically homogeneous, statistical ho-
mogeneity was also tested with a I2-test. We used the definition
from theCochraneHandbook for Systematic Reviews of Interventions
(Chapter 9.5.2) (Higgins 2011).
• 0% to 40%: might not be important
• 30% to 60%: May represent moderate heterogeneity
• 50% to 90%: May represent substantial heterogeneity
• 75% to 100%: Considerable heterogeneity
Assessment of reporting biases
We planned to use a funnel plot to identify publication bias. Also,
we investigated inconsistencies between the FDA trial registries
and published reports of trials. In general, we expected studies
comparing interventions for low-back pain to assess at least pain,
Oswestry (or similar) scores and to evaluate mobility/fusion of the
motion segment. If there were too many studies without these
parameters, reporting bias was suspected, unless confirmed by a
full protocol.
Data synthesis
The results from individual studies were pooled when the studies
were judged to be sufficiently homogeneous after the assessment
of heterogeneity (clinical and statistical).
We evaluated the quality of evidence for all outcome parameters,
regardless of quantitative analysis, using the GRADE approach
(GRADE Working Group 2004) and GRADE Profiler software,
most current version). In short, the quality of evidence was judged
from the presence of the following criteria (adapted from Furlan
2009).
• No risk of bias: 75% of studies with a low risk of bias (six or
more items met, no serious methodological flaws)
• No inconsistency: Studies have consistent findings
• No indirectness: Results are based on direct comparison
• No imprecision: Estimate of effect is sufficiently precise
(resulting from more than one trial, confidence interval narrow
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and conclusive, and more than 75% of studies contributing to
analysis)
• No publication bias: Analysis is free of reporting or
publication bias
Depending on how many criteria were met, we judged the quality
of evidence to be ’High’ (all criteria), ’Moderate’ (all but one), ’Low’
(all but two) or ’Very Low’ (all but three). Important outcomes for
which there were no trials were considered to have ’no evidence’.
An outcome with only one trial was automatically low quality and
if it also had a high risk of bias, it dropped to very low quality.
The clinical relevance of the review resultswas assessedwith the five
questions given in Appendix 3. The results of this assessment were
used to help in the discussion of the final results and conclusions.
Subgroup analysis and investigation of heterogeneity
When heterogeneity existed, we performed post-hoc subgroup
analyses and sensitivity analyses to explore the reason for hetero-
geneity. Analyses were performed for study design, (allocation con-
cealment, outcome assessor blinding, patient blinding), patient
characteristics (pain location, levels involved, age, gender) and im-
plant design (constraint, material).
Sensitivity analysis
Sensitivity analyses were planned to assess the effect of risk of bias
(high or low) on outcomes (primary, secondary and complica-
tions).
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies.
Results of the search
The search in the databases resulted in 3857 references (MED-
LINE 1358, EMBASE 2823, BIOSIS 365; CENTRAL 100, mi-
nus 789 duplicates). Kappa scores for the selection process were be-
tween 0.4 and 0.7 (moderate). We found 40 publications meeting
our inclusion criteria, describing seven unique studies (see Figure
1). Four FDA approved Investigational Device Exemption studies
were reported in one, two, 12 and 15 publications. SearchingClin-
icalTrials.gov resulted in four ongoing trials listed in the Ongoing
studies section, but no additional completed trials. Citation track-
ing was performed on January 9, 2012 and of 195 cites, 70 were
unique additional references but no new studies were found. For
characteristics of studies see Characteristics of included studies,
Characteristics of excluded studies and Table 1.
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Figure 1.
Included studies
Methods
Three studies were non-inferiority trials (Blumenthal 2005;
Gornet 2011; Zigler 2007) and one study was a superiority trial
(Hellum 2011). In two studies, design and hypothesis were not
described regarding superiority or non-inferiority, but these stud-
ies tested for superiority (Berg 2009; Moreno 2008). In one study,
design and hypothesis was also not described regarding superiority
or non-inferiority, but for this study with only single-centre, pre-
liminary results, the clinical outcomes were not statistically tested
(Sasso 2008).
Participants
All studies included adult patients with back or leg pain or both
in the presence of Degenerative Disc Disease (DDD) unrespon-
sive to conservative treatment for at least three or six months. All
studies included patients with one affected level, except for Berg
2009 which had 51% one-level procedures, and Hellum 2011
which included an unclear amount of one and two affected levels.
Zigler 2007 separately reported one- and two-level procedures.
Five studies (Berg 2009; Blumenthal 2005; Gornet 2011; Sasso
2008; Zigler 2007) mentioned facet joint arthritis/degeneration
as an exclusion criterion.
Interventions
Four types of total disc replacement were used in the stud-
ies, Charite (Charite III, De Puy Spine, Raynham, MA, USA),
Prodisc-L (Prodisc L or Prodisc II, Synthes Spine, West Chester,
PA, USA), Maveric (MAVERICK Disc, Medtronic, Memphis,
TN, USA), and Flexicore (Flexicore Intervertebral Disc, Stryker
Spine, Allendale, NJ, USA).
Six studies (Berg 2009; Blumenthal 2005; Gornet 2011; Moreno
2008; Sasso 2008; Zigler 2007) compared total disc replacement
with fusion. One study, Hellum 2011, compared Prodisc against
a rehabilitation protocol with cognitive treatment and physical
therapy.
Outcomes
All studies used the Oswestry Disability Index (ODI) and a VAS
pain score, specified as VAS back pain in three studies and com-
pleted with a VAS leg pain in one study. SF-36 was used in three
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studies. Follow-up was up to 24 months for all studies with one
study with a report of five-year results (Blumenthal 2005).
Excluded studies
In the published version of the protocol for this review, we antic-
ipated including non-randomised studies. The search and selec-
tion strategy as well as the ’Risk of via’ assessment were thus also
aimed at evaluating observational studies. In addition to two ob-
servational concurrently controlled studies (Cakir 2006; Schroven
2006), we excluded two studies that only looked at kinematics and
did not report clinical outcome (SariAli 2006; Tournier 2007),
and one study that was a retrospective study with a comparison
between two arthroplasty devices (Shim 2007). Cakir 2006 et al
specifically defined different selection criteria for the two inter-
ventions and this consequently resulted in two different groups
with associated distinct age categories. Details of these studies are
listed in Characteristics of excluded studies.
Risk of bias in included studies
Wecontacted all (seven) principle investigators of the trials for clar-
ifications about unclear or high ’Risk of bias’ items. Four responded
and their clarifications together with the ’Risk of bias’ assessment
adjustments are shown in the ’Risk of bias’ tables in Characteristics
of included studies (denoted: “investigator response:”). The clar-
ifications resulted in an upgrade of four items with an “unclear”
to “low risk of bias”. These four studies had in total 21 items with
“high” or “unclear” risk of bias. The final risk of bias for the studies
is given in Figure 2.
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Figure 2.
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Allocation
Five of the included studies (Berg 2009; Blumenthal 2005; Gornet
2011; Hellum 2011; Zigler 2007) used adequate randomisation
techniques, generated by computer programs or scrambled in a
box.
Two studies used sequentially numbered, sealed envelopes pro-
vided by the sponsor to attempt allocation concealment (
Blumenthal 2005; Gornet 2011). In one study, these were opened
after informed consent, and consecutively; only one case was ex-
cluded from the intervention (Gornet 2011). In the other study,
these were opened the day before surgery, and presumably no
patients dropped out or crossed over before the intervention
(Blumenthal 2005). One study only mentions sealed envelope
“with no possibility to see through” opened after informed con-
sent, and apparently no patients crossed over or dropped out (Berg
2009). One study had a co-ordinating secretary not involved in
the treatment who could access the allocation on the internet, pre-
sumably at all times, but allocation was disclosed after randomisa-
tion (Hellum 2011). For this study it was unclear how long before
intervention the allocation was disclosed, but 16 (of 173) partic-
ipants did not proceed to the allocated intervention. The other
studies did not mention allocation concealment (Moreno 2008;
Sasso 2008; Zigler 2007).
Blinding
Except for outcome assessor blinding in one study (Hellum2011),
blinding of any party is probably not used in any of the RCTs al-
though description of blinding was insufficient. Even then, for the
study by Hellum, the primary outcome measures were patient-re-
ported outcomes and the patients were not blinded. Care provider
blinding is obviously impossible in trials on surgical techniques
and implants. However, patient blinding and especially outcome
assessor blinding is feasible, but was not used in the included stud-
ies.
Regarding observer blinding,most of the (primary) outcomeswere
VAS pain and Oswestry scores. As these are self-report question-
naires, lack of assessor blinding has less influence on the risk of
bias than lack of patient blinding.
Incomplete outcome data
In general, the large FDA-IDE trials have acceptable loss to fol-
low-up between 10% and 12% at two years. However, one trial
represents only one centre in a multicentre trial (Sasso 2008), and,
as the author acknowledges, these results should be read carefully
until the complete patient sample has been reported upon. One
study (Hellum 2011) reported a drop-out of 19.6% (13 and 21
patients in the two groups), but of these, 26 patients returned a
questionnaire with the primary outcomes. The remaining studies
report loss to follow-up between 0% and 4%. Of note is the avail-
able data for the primary, composite, outcome parameter for the
study of Gornet 2011, although only reported in supplementary
tables, the loss to follow-up appears to be up to 22% for the to-
tal disc replacement group and 40% for the fusion group at 24
months follow-up.
For only one study (Blumenthal 2005) there is a report of five-
year follow-up. There is a high percentage loss to follow-up in
this report and thus a high risk of bias for the five-year follow-up
results. It was decided not to include these results as the percentage
loss to follow-up exceeded 20%.
Selective reporting
From the FDA IDE trials we received no protocols from the FDA
on the basis of the Freedom Of Information Act, but the applica-
tion is still pending. From the three non-FDA trials we received
no protocols from the authors. Hellum 2011 was registered on
clinicaltrials.gov, but after two years of inclusion. Moreover, we
assessed the descriptions in the trial registries valuable for preven-
tion of publication bias, but for the purpose of this review, insuf-
ficient in assessing reporting bias on detailed items, such as what
were exactly the primary and secondary outcome parameters and
at what time points, and which analyses were anticipated.
Other potential sources of bias
Sponsoring
Three studies were sponsored solely by commercial parties, being
the manufacturers of the total disc replacement devices (Gornet
2011:Medtronic; Sasso 2008: Stryker; Blumenthal 2005:DePuy).
For one study (Zigler 2007), funding and conflict of interest state-
ments were inconsistent across publications where the primary
publication mentioned no funding for the work at hand but au-
thors had received benefits from a commercial party related to
the subject. However, secondary publications for this study do
mention either funding, received benefits or both. One study
was funded by non-commercial parties (Hellum 2011: the South
Eastern Norway Regional Health Authority and EXTRA funds
from the Norwegian Foundation for Health and Rehabilitation,
through the Norwegian Back Pain Association). One study did
not receive financial support (Berg 2009). One study did not dis-
close information about funding or conflict of interest (Moreno
2008). A secondary publication from Berg 2009received financial
support for health economy calculations (DePuySpine, Synthes
and Medtronic).
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Baseline characteristics
For the comparison between total disc replacement and fusion,
baseline characteristics were fairly similar. One trial (Berg 2009)
has baseline differences forVAS leg pain,when evaluating the treat-
ment difference in change scores, the significance of the outcome
at two years diminished. Also, the change scores for back pain were
not significant in contrast to the uncorrected scores at two years.
Their primary outcome, a global assessment of back pain, has no
baseline value, but probably relies on the baseline pain levels and
therefore carries the risk of bias. Three other studies (Blumenthal
2005; Gornet 2011; Zigler 2007) reported change scores, but no
difference with the uncorrected scores were found.
Moreno 2008 has possibly differences in baseline for both pain and
Oswestry score, but this study did not perform statistical testing,
and no change scores are presented. Sasso 2008 did not report
baseline characteristics. The risk of bias from unbalanced baseline
characteristics from these studies is believed to be high. However,
the overall impact of these studies on the results of this review is
limited, as Sasso 2008 was not used for the analyses because it
represents only one centre of a multicentre trial and Moreno 2008
has only a sample size of 32 patients. Further, both were high risk
of bias studies and were excluded from the sensitivity analyses.
For the only study with a comparison between total disc replace-
ment and rehabilitation (Hellum 2011), baseline characteristics
were significantly different for secondary outcome scores back pain
and SF36 mental health score. The change from baseline scores
was still significantly different.
Co-interventions
The use of co-interventions was hard to evaluate. Many differ-
ent rehabilitation protocols and concurrent interventions could be
imagined. In general, as far as reported, the co-interventions were
considered standard across interventions.
Compliance
Compliance was generally not an issue in trials comparing dif-
ferent surgical techniques or implants. Only for the comparison
between disc replacement and rehabilitation, cross-over was an is-
sue, although cross-over from rehabilitation to surgery was within
reasonable limits and an intention-to-treat analysis was performed
in addition to a per protocol analysis.
Timing of outcome assessments
The well-protocolised FDA-IDE studies have guaranteed assess-
ment of outcomes within relatively standard and narrow time win-
dows. Only one study (Moreno 2008) had a difference between
the follow-up periods of the groups.
Heterogeneity
In general, there appeared to be no heterogeneity between the
different interventions on the I2 test. Only blood loss showed
considerable heterogeneity (94%). In addition, Oswestry at 24
months had an I2 of 39%, but we have not used this analysis in
the results as we only used improvements from baseline.
Effects of interventions
See: Summary of findings for the main comparison Disc
arthroplasty versus fusion for chronic low-back pain
Because of the high risk of bias due to possible selective report-
ing of the single-centre results (n = 76) of the FDA IDE study
on the FlexiCore by Sasso 2008, we decided not to include these
preliminary results in this version of the review. The data being
incomplete would have influenced the grading of the evidence as
the comparison is not free of publication bias and no decision can
be made about consistency of other studies with this study. The
only report with five-year follow-up (Blumenthal 2005) was ex-
cluded from analysis because of extensive loss to follow-up (up to
43%). Zigler 2007 separately reported one- and two-level proce-
dures, but for this report we only used the one-level results.
1. Disc arthroplasty versus fusion
Five studies (Berg 2009; Blumenthal 2005; Gornet 2011;Moreno
2008; Zigler 2007, one level) with 1301 patients were found that
compared total disc replacement (n = 865) with fusion (n = 436).
Charite was compared by Blumenthal 2005 (n=205) against ALIF
with BAK fusion cages (n = 99, Zimmer Spine,Minneapolis, MN)
and byMoreno 2008 (n=14) against ALIF with KLA cage (n = 18,
Scient’X, Guyancourt, France), iliac crest autograft and anterior
plate. Zigler 2007 compared one- and two-level procedures of
Prodisc (n = 161 and n = 165) against femoral ring allograft with
posterior pedicle screws and iliac crest autograft (n = 75 and n =
72). Berg 2009 compared Charite, Prodisc or Maverick (n = 80)
with fusion with local or iliac crest bone graft, posterior pedicle
screws, posterolateral or interbody fusion with Brantigan cage (n
= 72, DePuy Spine, Raynham, MA).
Four studies had a low risk of bias (Berg 2009; Blumenthal 2005;
Gornet 2011; Zigler 2007) and one study had a high risk of bias
(Moreno 2008).
Improvement in pain
All studies reported significant differences in improvement in ei-
ther leg or back pain or unspecified pain favouring total disc re-
placement at various short-term follow-up time points up to 12
months. “Improvement in pain” (not specified) was measured by
Blumenthal 2005 and Zigler 2007 at six weeks and three, six and
12 months where Blumenthal 2005 found a significant difference
at all follow-up time points and Zigler 2007 (one level) only after
three months. Berg 2009 measured “improvement in leg pain” at
12 and 24 months and found no differences. Gornet 2011 mea-
sured “improvement in leg pain” at six weeks and three, six and 12
months and found a difference at 12 months. Berg 2009 measured
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“improvement in back pain” at 12 and 24 months and found no
differences. Gornet 2011 measured “improvement in back pain”
at six weeks and three, six and 12 months and found a difference
at all follow-up time points.
At 24 months, all studies evaluated improvement of either leg or
back pain or unspecified pain. Two studies (Berg 2009; Gornet
2011)measured both “improvements in back pain” and “improve-
ments in leg pain”, but only one significant difference was found
for “improvement in back pain” favouring total disc replacement
in one study (Gornet 2011). Three studies (Blumenthal 2005;
Moreno 2008; Zigler 2007) did not specify the type of pain (“pain”
was assessed), but these studies did not provide an estimate of vari-
ability so results could not be pooled.
• There is low quality evidence from two low risk of bias
studies (Berg 2009; Gornet 2011) that the mean improvement in
VAS back pain at 24 months in the disc replacement group was
5.2 mm (out of 100) higher (676 patients; 95% CI 0.2 to 10.3,
see Figure 3) than in the fusion group. The quality of evidence
had to be decreased because of risk of publication bias and
imprecision.
Figure 3. Forest plot of comparison: 1 Disc replacement versus fusion, outcome: 1.3 Improvement in back
pain at 24 months.
• There is very low quality evidence from two studies (Berg
2009; Gornet 2011) that the difference between disc
replacement and fusion in mean improvement of VAS leg pain at
24 months was not statistically significant. The quality of
evidence had to be decreased because of risk of publication bias,
inconsistency and imprecision.
Overall improvement
The definition of overall improvement differed between the stud-
ies. Blumenthal 2005 defines clinical success as 25% improvement
of Oswestry score, no device failure, no major complications and
no neurological deterioration. Zigler 2007 uses the FDA criteria
needing an improvement in 10 endpoints, including Oswestry
score (two analyses; 15% and 15 points), SF-36, device success, ra-
diological success and neurological success. Gornet 2011 defined
a 15-point improvement also on a composite score including suc-
cessfull neurological status, disc height, no additional surgery and
no serious device or surgical procedure-related adverse events. The
composite variable appeared to suffer from the loss to follow-up of
the compound scores as only 313/405 and 103/172 were analysed.
Moreno 2008 defines excellent result as a 60% gain in Oswestry
and 50% gain in VAS pain. Berg 2009 did not define an overall
outcome. Meta-analysis could not be performed.
Patient satisfaction
All studies evaluated patient satisfaction, four studies (see below)
used a dichotomised measure and could be pooled. Zigler 2007
used a continuous VAS measure for patient satisfaction and found
a significant difference of 8.6 mm favouring total disc replacement
over fusion for one-level procedures and 8,8 mm for two-level
procedures. The questions on satisfaction were “would you have
the same treatment again”, “satisfied with results” and “would
recommend the intervention”.
• There is moderate quality evidence from four studies (Berg
2009; Blumenthal 2005; Gornet 2011; Moreno 2008) that
patient satisfaction at 24 months is more prevalent in the total
disc replacement group with an OR of 1.93 (958 patients; 95%
CI 1.36 to 2.76; see Figure 4) than in the fusion group. The
quality of evidence had to be decreased because of inconsistency,
two non-sponsored studies found no effect and two sponsored
studies found a statistically significant effect.
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Figure 4. Forest plot of comparison: 1 Disc arthroplasty versus fusion, outcome: 1.10 Patient satisfaction.
Back-specific functional status
All studies included an Oswestry score, other functional status
scores were not used. All four low risk of bias studies reported a
difference in improvement of the Oswestry score favouring total
disc replacement over fusion at various follow-up time points. At
six weeks, three months and six months differences were found
by three studies (Blumenthal 2005; Gornet 2011; Zigler 2007).
Additonally,Gornet 2011, Berg 2009 andBlumenthal 2005 found
adifference at 12months.Only one study (Gornet 2011), reported
a difference in improvement of Oswestry score favouring total disc
replacement at 24 months, while four other studies could not find
a difference. The pooled analysis, however showed a statistically
significant difference favouring disc replacement over fusion. The
level for improvement on the Oswestry score varied between the
studies from 25% to 50%.
• There is moderate quality evidence from five studies (Berg
2009; Blumenthal 2005; Gornet 2011; Moreno 2008; Zigler
2007) that the mean Improvement in Oswestry score at 24
months in the disc replacement group was 4.27 points (out of
100) better (1207 patients; 95% CI 1.85 to 6.68; see Figure 5)
than in the fusion group. The quality of evidence had to be
decreased because of inconsistency of the results as one found
significant effects and four found no significant effects.
• There is low quality evidence from five studies (Berg 2009;
Blumenthal 2005; Gornet 2011; Moreno 2008; Zigler 2007)
that patients in the total disc replacement group are more likely
to have been improved on the Oswestry scale at 24 months more
than a predefined level (1244 patients; OR 1.45, 95% CI 1.06 to
1.98; see Figure 5) than in the fusion group. The quality of
evidence had to be decreased because of inconsistency and
imprecision.
Figure 5. Forest plot of comparison: 1 Disc replacement versus fusion, outcome: 1.14 Percentage of
patients improved on Oswestry at 24 months.
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Well being, quality of life
Only two low risk of bias studies (Gornet 2011 and Zigler
2007, two level) reported mean and standard deviation of SF-36
scores. Zigler 2007 (one level) only reports the SF-36 success rate.
Blumenthal 2005 and Berg 2009 mention having used SF-36, but
do not report results. The results from Gornet 2011 show that
there are only very short term (1.5 and three months) differences
in improvement in mental component score favouring total disc
replacement. For the physical component score, the improvement
was significant at every follow-up and favoured total disc replace-
ment. Meta-analysis could not be performed. Because for both
one-and two-level procedures, there is only one study, only a low
quality of evidence can be appointed to this comparison.
Four studies reported working status at all follow-up measure-
ments (Gornet 2011), at three, 12 and 24 months (Berg 2009),
12 and 24 months (Blumenthal 2005) and at 24 months (Zigler
2007, one level). Only Gornet 2011 reports time to return-to-
work from aKaplan-Meier analysis, but with no indication of vari-
ability. The preoperative working status varied between the stud-
ies, limiting the analysis to a change in working status between
preoperative and 24 months.
• There is very low quality from four studies (Berg 2009;
Blumenthal 2005; Gornet 2011; Zigler 2007, one level) that the
difference in improvement working status at 24 months is not
statistically significantly different between disc replacement and
fusion. The level of evidence had to be decreased because of
inconsistency, possible reporting bias and imprecision.
Radiological and complications
• There is moderate quality evidence from four low risk of
bias studies (Blumenthal 2005; Gornet 2011; Zigler 2007, one
level; Berg 2009) that total disc replacement leads to a range of
motion that is more comparable to the preoperative status. All
four studies found a range of motion of total disc replacement up
to two years comparable to the preoperative status, while the
range of motion for fusion was nearly zero. The quality of
evidence had to be decreased due to inconsistent reporting with
the impossibility for meta-analysis. There was, however, a
dramatic effect allowing moderate quality of evidence.
• Only two studies mentioned thromboembolic
complications. Blumenthal 2005 mentioned two cases of venous
thromboses in the disc replacement group and none in the fusion
group. Gornet 2011 reports one cardiovascular event in the disc
replacement group and none in the fusion group. No meta-
analyses could be performed because the definition of
“cardiovascular event” in Gornet 2011 was not given.
• There is very low quality evidence from five studies (Berg
2009; Blumenthal 2005; Gornet 2011; Moreno 2008; Zigler
2007, one level) that there is conflicting evidence on the amount
of perioperative blood loss. The level of evidence had to be
decreased from high to very low because of imprecision,
inconsistency and reporting bias.
• There were 63 of 810 (7.8%) re-operations in the total disc
replacement group and 35 of 384 (9.1%) in the fusion group.
There is very low quality evidence from five studies (Berg 2009;
Blumenthal 2005; Gornet 2011; Moreno 2008; Zigler 2007, one
level) that the difference in re-operations up to 24 months was
not statistically significant. The quality of evidence had to be
downgraded because of imprecision, inconsistency and possible
reporting bias.
• Only one secondary publication of a low risk of bias study
(Blumenthal 2005) reported neurological complications and
found no difference between the two groups.
• There is very low quality evidence from one low risk of bias
study (Berg 2009) that the difference in adjacent segment
degeneration at 24 months was not statistically different. This
one study only marginally reported adjacent segment
degeneration mentioning six of 72 cases of fusion and only one
of 80 cases of total disc replacement with adjacent segment
problems. The level of evidence is very low because there was
only one trial and had to be decreased because of imprecision.
• There is very low quality of evidence from one low risk of
bias study (Berg 2009) that the occurrence of facet joint
degeneration is not statistically significantly different. The quality
of evidence had to be downgraded because of imprecision.
• Radiographic loosening was not adequately reported in any
of the studies. Zigler 2007 mentions one case of radiolucency in
the fusion group, but no criteria are defined.
• Subsidence was not adequately reported and/or defined in
any of the studies. Blumenthal 2005 reports average subsidence
in mm, but does not report numbers of patients above a
predefined margin. Gornet 2011 and Zigler 2007 (one level)
report number of patients with subsidence, but both studies do
not report the criteria for when subsidence was scored as present.
Also, both studies have a remarkable difference in subsidence (<
1% versus > 5%). Meta-analysis could not be performed.
• Polyethylene wear was not assessed in any of the studies.
Cost-effectiveness
One study reported cost-effectiveness in a secondary publication
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(Berg 2009). No difference in societal cost could be found while
from a healthcare perspective fusion was more costly. Since clinical
benefit was only small and because of the wide spread in possible
cost per quality adjusted life year gained, cost-effectiveness could
not be shown superior for either intervention.
2. Disc arthroplasty versus rehabilitation
One low risk of bias study (Hellum 2011) comparing disc replace-
ment (n = 86) with rehabilitation (n = 87) found significant differ-
ence in improvement on the primary outcome, theOswestry scale,
but not beyond the clinically relevant difference of 10 points. For
back pain and Oswestry score, mixed model analysis (all follow-
ups) and univariate analysis (at baseline and one and two years)
were presented, the last were used for analysis. No improvement
scores were reported for these outcome parameters, but “Treat-
ment effect” could be used for analysis of difference in improve-
ment, so analyses below are from the authors’ report.
Improvement in pain
• There is very low quality evidence from one low risk of bias
study (Hellum 2011) that the improvement of back pain at 12
months in the total disc replacement group is 14.0 mm higher
(152 patients; 95% CI 5.0 to 23.0 mm) than in the
rehabilitation group. Quality of evidence had to be decreased
because there was only one trial with an imprecise estimate.
• There is very low quality evidence from one low risk of bias
study (Hellum 2011) that the improvement of back pain at 24
months in the total disc replacement group is 12.3 mm higher
(152 patients; 95% CI 3.1 to 21.3 mm) than in the
rehabilitation group. Quality of evidence had to be decreased
because there was only one trial with an imprecise estimate.
Overall improvement
Overall improvement was not assessed or calculated in this study.
Patient satisfaction
• There is low quality evidence from one low risk of bias
study (Hellum 2011) that patients are more likely to be satisfied
with the outcome at two years in the total disc replacement
group (OR 2.65 95% CI 1.42 to 4.96) than in the rehabilitation
group. Quality of evidence had to be decreased because there was
only one trial.
Back-specific functional status
• There is low quality evidence from one low risk of bias
study (Hellum 2011) that the improvement of Oswestry score at
12 months in the total disc replacement group is 8.90 points
higher (172 patients; 95% CI 4.77 to 13.03 points) than in the
rehabilitation group. Quality of evidence had to be decreased
because there was only one trial.
• There is low quality evidence from one low risk of bias
study (Hellum 2011) that the improvement of Oswestry score at
24 months in the total disc replacement group is 6.90 points
higher (172 patients; 95% CI 2.23 to 11.57 points) than in the
rehabilitation group. Quality of evidence had to be decreased
because there was only one trial.
Well being, quality of life
• There is low quality evidence from one low risk of bias
study (Hellum 2011) that there is no statistically significant
difference in improvement of working status.
Radiological and complications
The one study evaluating total disc replacement with rehabilita-
tion did not measure any radiological parameters, thus implant
motion, adjacent segment degeneration, facet joint degeneration,
loosening, subsidence and polyethylene wear could not be anal-
ysed.
• Thromboembolic complications were reported for two
patients with total disc arthroplasty.
• Blood loss of more than 1500 cc was reported for four
patients.
• There is low quality evidence from one low risk of bias
study (Hellum 2011) that there is no statistically significant
difference in subsequent operation rate.
D I S C U S S I O N
Summary of main results
Effectiveness
Most studies show clinically important changes (Ostelo 2008)
from baseline for both interventions, being total disc replacement
on one hand and fusion or rehabilitation on the other. However,
the differences on the primary outcome parameters, including
their 95% confidence intervals, were smaller than these predefined
changes or the quality of evidence was of low or very low quality.
How do the clinical results compare to fusion, the only
surgical “gold standard” available?
The higher improvement in back pain for total disc replacement
(5.2 of 100 mm; 95% CI 0.2 to 10.3) did not exceed the prede-
fined clinically relevant difference (15 mm) with a low quality of
evidence. For other outcomes, moderate quality of evidence was
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only found for difference in improvement on the Oswestry score
at 24 months (4.3 points; 95% CI 1.85 to 6.68) in favour of disc
replacement, which also did not exceed the predefined clinically
relevant difference of 10 points. Patients reported higher satisfac-
tion with total disc replacement and the disc replacement devices
appeared to succeed in maintaining more natural motion char-
acteristics. Overall, the clinical differences were considered as be-
ing relevant in only one study. From none of the included studies
could we conclude that the likely clinical benefits, if present, could
be worth the possible potential harms (Table 2).
How do the clinical results compare to other treatment
options?
Only one study is available for the comparison between total disc
replacement with rehabilitation. The average effect for improve-
ment in back pain at 24months (12.3mm) is below the predefined
clinical relevant difference of 15 mm although there is a chance
(95% CI 3.1 to 21.3) that the clinical outcome is superior for
total disc replacement. This conclusion could also apply on the
improvement in Oswestry score (8.4 points; 95% CI 3.6 to 13.2).
However, evidence for this comparison was considered of low or
very low quality, because it was based on only one low risk of bias
trial.
Safety
What are the radiologic results with regards to loosening,
subsidence (slippage) of the implant into the vertebral
bodies, and polyethylene wear?
Radiological results are poorly reported across the studies. Very few
data are available and where reported, definitions are not provided.
Does the motion segment retain its mobility? And if it does,
do these motions resemble a normal motion segment?
There is limited amount of evidence thatmotion segmentmobility
is preserved through disc replacement. Although it can be argued
that clinical studies evaluating the effectiveness of disc arthroplasty
should always include the assessment of mobility, motion assess-
ment was only presented in three of the studies (Blumenthal 2005;
Gornet 2011; Zigler 2007). However, the data presentation per-
taining to motion was poor limiting the possibility for meta-anal-
ysis. These studies found that total disc replacement showed range
of motion comparable to preoperative range of motion, while fu-
sion surgery lead to (nearly) absence of motion as would be ex-
pected.
We have to comment that our search and selection process was
not aimed at finding studies that exclusively valuated the mobility
of total disc replacement without assessment of clinical outcome,
thus the included randomised studies could be not representative.
However, two excluded studies (SariAli 2006; Tournier 2007) and
one secondary publication (Zigler 2007) confirmed our findings.
A comparable mobility with healthy volunteers was found by
SariAli 2006 inpatientswith disc arthroplasty at one level, butwith
more than one level, the mobility was abnormally increased. The
secondary study for Zigler 2007 also finds physiological motion
profiles for flexion-extension for operative and proximal levels.
Can the total disc replacement reduce the incidence of
adjacent segment degeneration compared to fusion?
We did not find conclusive evidence of a beneficial effect of total
disc replacement versus fusion on adjacent segment degeneration
at relevant long-term follow-up. Only one study assessed adjacent
segment degeneration (Berg 2009), but could not make a precise
estimate of the effect due to a limited sample size and low inci-
dence of adjacent segment degeneration at the short-term follow-
up of two years. Ultimately, as the population receiving total disc
replacement is relatively young, adjacent segment degeneration
needs to be assessed at the long term. For example, Putzier 2006
found 17% adjacent segment degeneration after 17.3 years in 53
patients in a cohort of the Charite disc replacement.
What is the incidence of facet joint degeneration at the
operated level?
Most studies excluded patients with facet joint degeneration. On
the development of facet joint degeneration after implantation of
a disc replacement, there is insufficient evidence. Only one study
reports facet joint degeneration (Berg 2009) with an imprecise es-
timate due to very low incidence at two-year follow-up. The as-
sessment of facet joint degeneration appears relevant as the flex-
ion/extension appears to be comparable to normal, but especially
if the axis of rotation is altered the motion might conflict with the
facet joints.
How does the perioperative complication rate compare to
fusion operations?
Perioperative complications are not adequately and consistently
reported between the studies. Blood loss showed great heterogene-
ity and thrombo-embolic complications were only reported in one
study. From these studies it is not clear how the perioperative com-
plication rate of total disc replacement compares with fusion pro-
cedures.
“Is there an acceptable and safe salvage procedure in case of
failure?
Gornet 2011 mentions two removals of disc arthroplasty due to
epidural abscess and allergic reaction. Berg 2009 mentions fusion
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of four disc arthroplasty procedures close to the 24 month fol-
low-up. It was difficult to link the failures of the device to sal-
vage procedures and outcome. Definition of ”failure“ varies and
it was difficult to classify failures as ”device related“. Outcomes
of possible salvage cases were not reported in one study (Gornet
2011). Posterior decompression through laminectomy might very
well have been necessary for pain due to stenosis of the foramen
with extension. One secondary study reports on the revisability
of the total disc replacement from their trial (Blumenthal 2005)
and concluded that one third could be revised to a new total disc
replacement and that two thirds of patients could be revised to a
fusion procedure. Recent studies on revisability (de Maat 2009)
show that revision is possible, but not without (vascular) compli-
cations and with highly variable outcome (Punt 2008).
Overall completeness and applicability of
evidence
Although clearly presented, the extensive selection criteria in the
FDA-IDE trials (Blumenthal 2005; Gornet 2011; Sasso 2008;
Zigler 2007) result in a very select patient sample regarding height
loss, age and presence of any comorbidity. This limits the external
validity of the results of these trials, and precludes extrapolation
to the application of total disc replacement in all patients with
degenerative disc disease.
The surgical techniques were fairly well described, although co-
interventions such as the rehabilitation protocol used lack detailed
description. There were few comparable control groups between
the studies. Only the control groups of Berg 2009 and Zigler
2007, which both use circumferential fusion, are sufficiently com-
parable. Although both Blumenthal 2005 and Gornet 2011 use a
stand-alone cage, Gornet 2011 fills the cage with a bone substitute
whereas Blumenthal 2005 uses iliac crest autograft. The BAK cages
used by Blumenthal 2005 have been criticized for resulting in large
numbers of patients with unacceptable outcome. Since superiority
of any technique in lumbar fusion for degenerative disc disease has
not yet been established, these results were pooled when statistical
heterogeneity was absent. However, future evidence about relative
effectiveness of these interventions could warrant subgroup anal-
yses. A systematic assessment of the evidence on this topic is thus
dearly needed.
The most relevant outcome parameters, pain, disability with Os-
westry score and return to work are used, and although statisti-
cally significant differences were found, no clinically relevant dif-
ferences were found when these were compared with the clinically
important differences as defined by Ostelo 2008. However, these
guidelines were defined as a meaningful change from baseline for
an intervention on an individual basis, whereas the clinically rel-
evant difference in effect between two groups might be different.
Although we agree that differences at the group level might be
somewhat smaller than improvements at the individual level, rel-
evant differences at the group level between surgical interventions
for low-back pain have not been published in the literature. For
this review we had to rely on the best information available on
clinically relevant differences. Furthermore, the studies only re-
ported the percentage of the patients that improved more than a
predefined level for the Oswestry score. On top of this, the pre-
defined level varied between 25%, 30% and 50%. Therefore, the
interpretation of the results was also supported with the results of
the clinical relevance score from Table 2. The Oswestry score as
used by Zigler 2007 was an adapted version of the official validated
version. The adaptation probably raised the baseline levels, allow-
ing more room for improvement. Their estimate of improvement
on the Oswestry score can thus be regarded as an overestimate.
Quality of the evidence
Although the risk of bias of five studies could be considered low,
the most important items, sequence generation, allocation con-
cealment, blinding, and comparable baseline values were not met
in most studies.
Potential biases in the review process
Publication bias
Sasso 2008 only represents a sub analysis from amulticentre study.
This study is included but results were not used for meta-analytic
purposes. The data being incomplete would have influenced the
grading of the evidence as the comparison is not free of publication
bias andnodecision canbemade about consistency of other studies
with this study.
Evidence from the current observational studies could not be used
because of the high risk of bias. We had felt that non-randomised
studies could have contributed to the total evidence as there are
many concerns in randomised surgical studies with blinding and
randomisation. Further, non-randomised studies could have addi-
tional value for external validity of the evidence and for assessing
the risk of complications in a wider range of patients than those
usually included in strict randomised trials.Non-tandomised stud-
ies should however, be very clear about patient selection and should
incorporate independent, blinded outcome assessment. This was
certainly not the case in those considered for inclusion in this re-
view and, therefore, these studies were excluded.
Sensitivity analyses
There were only two high risk of bias studies (Moreno 2008; Sasso
2008). Sasso 2008 was excluded from all analyses. Excluding the
small study by Moreno 2008 from the analysis did not influence
the quality of evidence and had only very limited effect on the
estimate for improvement in Oswestry score at 24 months.
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Subgroup analyses for patients with one- and two-level procedures
could not be performed because these results were not presented
separately in two of the three studies including two-level proce-
dures (Berg 2009; Hellum 2011). Zigler 2007 separately reported
one- and two-level procedures and the results appear to be differ-
ent. Berg 2009 states no difference in outcome between one- and
two-level procedures, but no data are provided. Excluding Berg
2009 from the comparison against fusion did not influence the
quality of evidence and had only a limited effect on the estimate
for improvement in Oswestry score at 24 months. For improve-
ment in back and leg pain, quality of evidence would be reduced,
because only one study remained for this comparison.
Agreements and disagreements with other
studies or reviews
Our previous systematic review (de Kleuver 2003), included only
case series and concluded that disc replacement seemed to be as-
sociated with a high rate of re-operations. On that evidence, disc
replacement was considered to be an experimental procedure, only
to be applied in strict clinical trials. Two early reviews (Freeman
2006; Randolph 2006) published after the first clinical results
of comparisons against fusion concluded that there was no evi-
dence that disc replacement reduced adjacent segment degener-
ation and that more independent, long-term prospective studies
were needed to systematically evaluate success and failure of this in-
novative technique. Two recent systematic reviews included three
(Van den Eerenbeemt 2010) and four (Yajun 2010) trials. Van
den Eerenbeemt 2010 raises questions about the external validity
of the trials as carefully selected patients were included. Further,
the relevance of the size of the effect is small, as was found in our
review. The conclusions of Yajun 2010 lack reliability because of
duplicate inclusion of the same study (using a secondary reference
(results of one centre) next to the primary (multicentre) reference).
Both reviews suggest that the use of BAK cages is no longer indi-
cated as a comparator giving more relevance to the comparisons
with circumferential fusion as in the Prodisc-L study. In our review
we could not find distinct differences between the different ap-
proaches for fusion. In line with the previous reviews, we conclude
that still more studies and longer-term follow-up assessments are
needed to asses the effectiveness and safety of this device.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Disc replacement compared with conventional fusion surgery for
degenerative disc disease appears to result in clinically irrelevant
superiority with respect to pain relief, Oswestry andQuality of Life
in a selected population, so far only for the short term. Currently
available trials did not assess adjacent level disease and facet joint
degeneration properly, which is a shortcoming as this is the reason
the product was manufactured. Therefore, because we believe that
harm and complications may occur after years, we believe that
the spine surgery community should be prudent about adopting
this technology on a large scale, despite the fact that total disc
replacement seems to be effective in treating low-back pain in
selected patients, and in the short term is at least equivalent to
fusion surgery. Otherwise, if equivalence can be assumed along
the proposedmethodology, use of these expensive implants should
remain limited including informed consent andmandatory quality
assessment in registries similar to the recommendations for metal-
on-metal (MoM) hip prostheses (Sedrakyan 2011).
Implications for research
Despite the publication of several recent studies on the effec-
tiveness of total disc replacement, there are still additional trials
needed, with less conflict of interest. Since only one trial compared
total disc replacement with conservative treatment, this design
needs to be replicated. Current ongoing studies all compare dif-
ferent brands of total disc replacement, thus these will not provide
this additional evidence. Most important are long-term follow-up
studies as differences in adjacent segment degeneration will only
then be identified. Furthermore, prosthesis-related complications
such as wear and loosening are likely to develop after longer im-
plantation periods. In order to better evaluate clinically relevant
group differences, research and consensus are needed on the clin-
ical relevant differences between (surgical) interventions for low-
back pain (Dworkin 2009).
Implications for those planning a total disc replacement trial
Choose current established interventions as control group, i.e. cir-
cumferential fusion or conservative treatment. Assessment of mo-
bility at index level with facet joint degeneration as well as mobil-
ity at adjacent levels with adjacent segment degeneration needs to
be performed to assess safety. Provide supplementary tables with
scores at all follow-up time points with indication of variability,
as well as changes from baseline with indication of variability.
Also, provide the reader with sample sizes and numbers of patients
followed up for each outcome parameter at each follow-up time
point.
Implications for other reviewers
For a better understanding of the effectiveness of total disc re-
placement, future reviews should be able to make more efficient
use of the collected data in the studies, published as well as un-
published, especially from the FDA IDE trials. Individual patient
data meta-analysis can provide a more powerful analysis and offers
more possibilities for subgroup analyses. There were four out of
seven responses to the author queries pertaining methodological
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information, which makes patient data sharing promising. This
step could improve the quality assessment of included studies, but
the responses need to be published and regarded peer-reviewed
information, in addition to the original publication. This review
needs to be updated on a relatively short notice as new information
from the ongoing trials will become available in the near future.
The ongoing studies will specifically evaluate the relative effective-
ness of disc replacements amongst each other. Both the studies
on Activ-L versus Prodisc or Charite (Aesculap Impl syst 2007),
and Kineflex versus Charite (SpinalMotion 2006) have passed the
anticipated primary outcome evaluation. Studies on the Freedom
disc versus an unknown control disc replacement device (Axiomed
Spine Corp 2008) and on the Nubac nucleus replacement ver-
sus Prodisc (Pioneer 2009b) are anticipated to end respectively in
2012 and 2014.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [author-defined order]
Berg 2009
Methods RCT, method unclear, allocation concealed with sealed envelopes
Participants LBP > 1 year, LBP > Leg pain, ODI > 30 or back pain VAS > 50
DDD, 1 or 2 level, MRI degeneration
20-55 years
> 3 mo conservative treatment, no previous lumbar fusion, previous decompression
No: spinal stenosis, spondylolysis, spondylolisthesis, facet joint arthritis,major deformity,
osteoporosis, previous spinal infection, spinal tumour, compromised vertebral body
Interventions Total disc replacement: Chrite, Prodisc or Maverick
Control: Fusion with local or iliac crest bone graft, Pedicle screws, posterolateral or
interbody fusion with Brantigan cage
Outcomes VAS leg, VAS back, SF 36, ODI, EQ5D, work status @ preoperative, 1 and 2 years
Notes Total disc replacement superior to fusion at one year, equal at 2 years
Design and hypothesis not described regarding superiority/non-inferiority, tested for
superiority
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Not described. Investigator response: ”The
randomizationwaswith pre-ordered sealed
envelope technique, that means that before
the study 200 envelopes,with no possibil-
ity to look through them were prepared.
In 100 a folded paper with the line “fusion”
was written, in the other 100 the folded
paper had the line “TDR”. All envelopes
were then sealed.The envelopes were then
carefully scrambled and the box with all
the envelopes were delivered the our pa-
tient coordinators office, and never again
came close to any of the health staff. When
a patient that had entered the study was
scheduled for surgery and admitted to the
hospital, one of the coordinators draw one
envelope, and that decided what type of
surgery that was provided. There was also
a stratification between the three different
prostheses. If a patient was randomized for
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Berg 2009 (Continued)
TDR, there were another two different
boxes, one for one-level cases and one for
two-level cases. Each of these boxes con-
tained 90 pre-ordered sealed envelopes, 30
of the respective three brands of prostheses
used for the study. The high number of en-
velopes in these “stratification-boxes” was
due to the fact thatwe from the start did not
know how the proportion of one- and two-
level cases would actually be.“ (upgraded)
Allocation concealment (selection bias) Low risk Sealed envelopes
Blinding (performance bias and detection
bias)
All outcomes - Participants?
High risk Not mentioned. Investogator response:
”The patients were not blinded to the type
of treatment that they were randomized to.
That means that either the evening before
surgery or at the latest the morning of the
day of surgery, they were informed by their
attending surgeon the result of the random-
ization. Since the two compared treatments
had totally different approaches, it was not
possible to blind the patients.“
Blinding (performance bias and detection
bias)
All outcomes - Care providers?
High risk Not possible. Investigator response: ”The
care provider was not blinded, the same rea-
son as above.“
Blinding (performance bias and detection
bias)
All outcomes - Observers?
High risk Not mentioned. Investigator response:
”Outcome was only assessed by the pa-
tients. The patients had questionnaires sent
home to fill out, and the questionnaires
were then sent the central registration of-
fice of the Swedish National Spine registry
(SweSpine). The questionnaires thus never
came into the hands of any of the care
providers.“
Incomplete outcome data (attrition bias)
All outcomes - drop-outs?
Low risk
Incomplete outcome data (attrition bias)
All outcomes - ITT analysis?
Low risk
Selective reporting (reporting bias) Unclear risk No protocol was found
Characteristics similar at baseline? High risk VASpainwas significantly different at base-
line. Investigator response: The two groups
were at all baseline data (VAS for back-
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Berg 2009 (Continued)
pain, Oswestry, SF-36, EQ5D, time of
sick-leave, earlier surgery, work load, other
sickness etc.) very similar. The only differ-
ence was at VAS for leg pain. This differ-
ence we have understood as a random sig-
nificance, and since outcome regarding leg-
pain was not the main focus of the study,
less important
Co-interventions avoided or similar? Low risk
Compliance acceptable? Low risk
Timing of outcome assessments similar? Low risk
Blumenthal 2005
Methods Multicentre RCT, computer-generated (SAS), 2:1, block size 6. Allocation concealment
with sealed envelopes
Participants Back and or leg pain
ODI > 30, VAS > 40
DDD, single level, L4-S1, discography confirmed,
18-60 years, no morbid obesity
> 6 months conservative treatment, no previous fusion TH1-S1, no chronic steroid use,
no use of bone growth stimulator
no: nerve root compression, noncontained HNP, spondylosis, spondylolisthesis > 3mm,
scoliosis > 8º, positive straight leg test, spinal tumour, osteoporosis, osteopenia,metabolic
bone disease, infection, psychosocial disorder, metal allergy, arachnoiditis, autoimmune
disorder
Interventions Total disc replacement: Charite
Control: BAK (2 cages) with iliac crest autograft
Outcomes VAS back pain, ODI, SF-36, neurological status, patient satisfaction @ preoperative, 6
weeks, 3, 6, 12 and 24 months
ROM, disk height, neuroforaminal height, segmental translation @ preoperative, 3, 6,
12 and 24 months
Notes Total disc replacement at least equivalent to fusion (ALIF)
Non-inferiority trial
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk
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Blumenthal 2005 (Continued)
Allocation concealment (selection bias) Low risk
Blinding (performance bias and detection
bias)
All outcomes - Participants?
High risk Non-blinded study
Blinding (performance bias and detection
bias)
All outcomes - Care providers?
High risk Not possible
Blinding (performance bias and detection
bias)
All outcomes - Observers?
High risk nNon-blinded study
Incomplete outcome data (attrition bias)
All outcomes - drop-outs?
Low risk
Incomplete outcome data (attrition bias)
All outcomes - ITT analysis?
Low risk
Selective reporting (reporting bias) Unclear risk No protocol was found
Characteristics similar at baseline? Low risk
Co-interventions avoided or similar? Low risk
Compliance acceptable? Low risk
Timing of outcome assessments similar? Low risk
Gornet 2011
Methods Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Participants DDD confirmed by plain radiography, CT or MRI
Back pain w/wo leg pain
L4-S1
Single level
Oswestry > 30
Back pain > 20
> 6 month conservative treatment
18-70 years
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Gornet 2011 (Continued)
Interventions Device: MAVERICK Disc
Device: Anterior fusion with LT-CAGE® Lumbar Tapered Fusion Device and IN-
FUSE® Bone Graft (Fusion)
Outcomes Primary OutcomeMeasures: Overall Success =Oswestry Disability Index success; Main-
tenance/improvement in neurological status; Disc height success; No serious AE classi-
fied as implant or implant/surgical procedure associated; No additional surgical proce-
dure classified as failure [ Time Frame: 24 Months ] [ Designated as safety issue: Yes ]
Secondary Outcome Measures: SF-36; Back Pain Status; Leg Pain Status; Patient Satis-
faction; Patient Global Perceived Effect; Other Measurements- Radiographic; Return to
Work; Doctor’s Perception of Results [ Time Frame: 24 Months ] [ Designated as safety
issue: Yes ]
Notes Non-inferiority trial
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Not described, 2:1 fixed block size but not
described how blocks were filled. Author
response: “The sponsor (Medtronic) cen-
trally ran the randomization schedule strat-
ified by site with SAS Proc Plan. The ran-
domization was in a 2:1 ratio and with a
fixed block size of 6. The following is what
described in the protocol: “Both the inves-
tigator and the patient will be blinded to
the randomization prior to informed con-
sent.Upon ensuring that the informed con-
sent form has been properly completed, the
investigator or designee will open the en-
velope that corresponds to the patient’s as-
signed clinical trial number to determine
if the patient will be randomized into the
investigational or control group. The pa-
tient and surgeon will not be blinded fol-
lowing the opening of the treatment enve-
lope.“ (upgraded)
Allocation concealment (selection bias) Low risk
Blinding (performance bias and detection
bias)
All outcomes - Participants?
Unclear risk Not described
Blinding (performance bias and detection
bias)
High risk Not possible
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Gornet 2011 (Continued)
All outcomes - Care providers?
Blinding (performance bias and detection
bias)
All outcomes - Observers?
Unclear risk Not described
Incomplete outcome data (attrition bias)
All outcomes - drop-outs?
Low risk
Incomplete outcome data (attrition bias)
All outcomes - ITT analysis?
Low risk Only one patient crossed over, per protocol
analysis was performed
Selective reporting (reporting bias) Unclear risk No protocol was found
Characteristics similar at baseline? Low risk
Co-interventions avoided or similar? Low risk
Compliance acceptable? Low risk
Timing of outcome assessments similar? Low risk
Hellum 2011
Methods Allocation: Randomized
Control: Active Control
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
Participants Chronic Low-back pain
Degenerative Disc Disease confirmed by imaging
Interventions Device: Total Disc Prosthesis
Behavioral: Multidisciplinary rehabilitation program
Outcomes Primary Outcome Measures: Oswestry Disability Index
Cost-effectiveness (full economic analysis)
Secondary Outcome Measures: Side effects
Time out of work
Fear - avoidance beliefs
Self - efficacy for pain
Hopkins symptoms check list
Drug consumption
Life satisfaction (EQ 5D and SF - 36)
Notes Superiority trial
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Hellum 2011 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Not described: ”They were randomized in
Blocks“, but unclear how the blocks were
filled. Investigator response: ”The size of
the blocks at each center varied from 2 to
8.“ (upgraded)
Allocation concealment (selection bias) Unclear risk Uncertainty about period between disclo-
sure and intervention. Sixteen participants
did not start allocated intervention. Inves-
tigator response: ”Group allocation was
generated by a web-site. A coordinat-
ing secretary, without information about
the patient, conducted the web-based ran-
domisation after the patient were found eli-
gible and had signed written informed con-
sent. Thereafter, the coordinating secretary
informed the patient about group alloca-
tion. All patients should receive their treat-
ment before 3 months after disclosure/ran-
domization. Reasons for patients not re-
ceiving allocated intervention are listed in
the flow-chart fig. 1 in the paper.“
Blinding (performance bias and detection
bias)
All outcomes - Participants?
High risk Not possible
Blinding (performance bias and detection
bias)
All outcomes - Care providers?
High risk Not possible
Blinding (performance bias and detection
bias)
All outcomes - Observers?
High risk Only 2 years Prolo score and back perfor-
mance scale blinded assessment was per-
formed. Not described for all other out-
comes. Investigator response: ”At two year
follow-up (the studies main endpoint), all
data (also questionnaires / main out-
come (ODI)) were collected by blinded
evaluators. Data at all other follow-ups
were collected by coordinating secretaries
not involved in the trial.
All datawere punched into SPSS by persons
without knowledge about the trial (univer-
sity students from non-medical disciplines)
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Hellum 2011 (Continued)
.“
Incomplete outcome data (attrition bias)
All outcomes - drop-outs?
Low risk
Incomplete outcome data (attrition bias)
All outcomes - ITT analysis?
Low risk
Selective reporting (reporting bias) Unclear risk No protocol was found. Investigator re-
sponse: ”We published our protocol www.
clinicaltrial.gov NCT 00394732. We also
sent British Medical Journal our protocol
shortly after we submitted the manuscript
to the BMJ. Other publications were not
performed.“
Characteristics similar at baseline? High risk Pain scores (primary outcome) and SF36
scores different between groups. Investiga-
tor response: ”In our original protocol, we
did not prespecify that differences consid-
ered to by chance (duo to the randomiza-
tion process) should be adjusted for. There-
fore British Medical Journal did not want
to publish adjusted values.When adjusting
for these differences, the difference in out-
come between groups were larger in favour
of surgery.“
Co-interventions avoided or similar? Low risk
Compliance acceptable? Low risk
Timing of outcome assessments similar? Low risk
Moreno 2008
Methods RCT, method unclear
Participants Chronic LBP
DDD, single level, L4-S1, no instability, Modic 1 or 2 on MRI
< 55 years
> 6 months conservative treatment, previous discectomy or chemonucleolysis allowed
no spondylolisthesis, no HNP, no stenosis
Interventions Total disc replacement: Charite III
Control: ALIF with KLA cage, iliac crest autograft and anterior plate
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Moreno 2008 (Continued)
Outcomes VAS, ODI @ preoperative, 6 months and latest (23 or 26 months)
Return to work @ 6 months
Satisfaction @ latest
Notes Conclusions: total disc replacement is possible alternative to fusion in severe DDD in
young participant. More rapid and superior results
Design and hypothesis not described regarding superiority/non-inferiority; tested for
superiority
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not described
Allocation concealment (selection bias) Unclear risk Not described
Blinding (performance bias and detection
bias)
All outcomes - Participants?
High risk Allocation was clear because of insurance issues
Blinding (performance bias and detection
bias)
All outcomes - Care providers?
High risk Not possible in surgery trials
Blinding (performance bias and detection
bias)
All outcomes - Observers?
High risk Not described
Incomplete outcome data (attrition bias)
All outcomes - drop-outs?
Low risk
Incomplete outcome data (attrition bias)
All outcomes - ITT analysis?
Low risk
Selective reporting (reporting bias) Unclear risk No protocol was found
Characteristics similar at baseline? Unclear risk Sufficient information not given
Co-interventions avoided or similar? Low risk
Compliance acceptable? Low risk
Timing of outcome assessments similar? High risk Follow-up differed between groups (23 vs 26 months)
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Sasso 2008
Methods Multicentre RCT, method unclear
Participants Discogenic pain, Axial pain > radicular pain
DDD, single level, L1-S1, MRI/CT/FEX instability (translational >2 mm, rotational
>5º, height loss >2 mm)
18-60, skeletally mature, BMI <40
Conservative treatment failed, no previous decompression or microdiscectomy
No: spondylolisthesis, stenosis, Scoliosis > 10 degrees, metabolic bone disease, RA, HIV,
Malignancies
Interventions Total disc replacement: Flexicore
Control: Circumferential fusion with femoral ring allograft, pedicle screws and iliac crest
autograft
Outcomes ODI, VAS back pain @ Preop, 6 weeks, 3, 6, 12 and 24 months
Blood loss, operation time and length of stay
ROM on flexion extension x-rays @ preoperative and 6 weeks
Notes This study reports on a sub sample (2 sites)
Conclusion: Flexicore compares very favourably to circumferential fusion for lumbar
DDD
Design and hypothesis not described regarding superiority/non-inferiority; clinical out-
come not tested
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not described
Allocation concealment (selection bias) Unclear risk Not described
Blinding (performance bias and detection
bias)
All outcomes - Participants?
Unclear risk Not described
Blinding (performance bias and detection
bias)
All outcomes - Care providers?
High risk Not possible
Blinding (performance bias and detection
bias)
All outcomes - Observers?
Unclear risk Not described
Incomplete outcome data (attrition bias)
All outcomes - drop-outs?
High risk Subgroup of larger trial
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Sasso 2008 (Continued)
Incomplete outcome data (attrition bias)
All outcomes - ITT analysis?
Unclear risk Not mentioned
Selective reporting (reporting bias) Unclear risk No protocol was found
Characteristics similar at baseline? Unclear risk Insufficient information given
Co-interventions avoided or similar? Low risk
Compliance acceptable? Low risk
Timing of outcome assessments similar? Low risk
Zigler 2007
Methods Multicentre RCT, method unclear, allocation concealment unclear
Participants Back and/or leg (radicular) pain, ODI > 40,
DDD, single level, L3-S1, CT/MRI/diskography/FEX (instability > 3 mm translation, >
5º angulation; disc height decrease > 2 mm; scarring/thickening annulus; HNP; vacuum
phenomenon)
18-60 years
> 6 months conservative therapy, no previous fusion
No: vertebral endplates < 34.5x27 mm, metal allergy, spondylolisthesis, spondylosis,
osteoporosis, Paget, osteomalacia,metabolic bone disease, deg spondylolisthesis > 1, BMI
> 40, AIDS, HIV, active malignancy
Interventions Total disc replacement: Prodisc-L
Control: Circumferential fusion with femoral ring allograft with pedicle screws and iliac
crest autograft
Outcomes VAS, ODI, SF-36, Physical exam, neurological exam @ preoperative, postoperative, 6
weeks, 3, 6, 12, 18 and 24 months
Notes Conclusion: Prodisc-L is safe and efficacious. In selected patients better than circumfer-
ential fusion
Non-inferiority trial
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Not described - Investigator response:
”Randomizationwas performed external to
both the sponsor and the investigator sites
by an independent third party, in overlap-
ping blocks of six patients at each site. The
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Zigler 2007 (Continued)
randomization schedule was not available
to either the sponsor or the investigator at
any time during the study. Patient demo-
graphics showed so significant differences
between the study group populations. The
schedule was generated externally, so I have
no idea what the technical aspects were. I
would assume itwas computer generated
because blocks of six were used for each
site, with each site maintaining an in-
ternal 2:1 randomization. Thus, even if
the last two patients had randomized to
fusion, there was no predictor that the
next patient would get an ADR because
the fusion patients might have been at
the end of a six-block, and next patient
might be at the beginning of the follow-
ing block. This is a perfect job for a com-
puter-generated algorithm.“
(upgraded)
Allocation concealment (selection bias) High risk Sponsor provided allocation after con-
sent. Investigator response: ”Allocationwas
made available to the investigator and spon-
sor only after the patient was enrolled. Al-
location to the investigator was necessary
for surgical planning, as the investigational
surgery required two hours of Operating
Room time, and the Control arm proce-
dure required 4-5 hours of OR time, uti-
lizing different instruments and implants.
There were no withdrawals due to surgeon
displeasure. There were approximately 30
additional patients who were enrolled but
not treated, the majority due to insurance
denials for surgery, completion of enrol-
ment by the time their insurance was ap-
proved, and a small number due to im-
provement in symptoms by the time insur-
ance was approved. Since they received no
surgery, and were not followed any longer,
there is no postop data to include.“
Blinding (performance bias and detection
bias)
All outcomes - Participants?
High risk This was a non blinded study. Investigator
response: ”Patients were blinded through
the enrolment and preoperative processes,
andwere not toldwhich group theywere al-
located into until they awoke from surgery.
No patient was informed prior to surgery,
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Zigler 2007 (Continued)
and there were consequently no patient
withdrawals among the 292 subjects due to
displeasure with their allocation.“
Blinding (performance bias and detection
bias)
All outcomes - Care providers?
High risk Not possible. Investigator response: ”Care
providers were not blinded.“
Blinding (performance bias and detection
bias)
All outcomes - Observers?
Unclear risk Not described. Investigator response: ”The
study results depended upon a complex
endpoint of 10 separate success criteria. In-
vestigator input was limited to only one
category, Neurologic Status (consisting of
recording the motor, sensory, and reflex ex-
ams as well as a Straight Leg Raise test).
The remaining nine success criteria were ei-
ther patient generated (VAS pain, VAS sat-
isfaction, ODI, SF-36) or recorded by in-
dependent radiologists based upon 5 radio-
graphic success criteria determined by their
off-site review of digitized films.“
Incomplete outcome data (attrition bias)
All outcomes - drop-outs?
Low risk Investigator response: ”Five patients were
treated off-protocol (for example, a two-
level fusion decision made by the Operat-
ing Surgeon at the time of surgery). Their
data was followed for safety, but was ex-
cluded from the efficacy calculation.“
Incomplete outcome data (attrition bias)
All outcomes - ITT analysis?
Low risk
Selective reporting (reporting bias) Unclear risk No protocol was found. Investigator re-
sponse: ”This study had a 98% follow-
up rate at the two-year postop reporting
threshold for the FDA. As primary au-
thor, I was satisfied that this extraordinarily
high follow-up rate ensured that all avail-
able data was included in the analysis from
all sites, and that there was no significant
opportunity for reporting bias.“
Characteristics similar at baseline? Low risk
Co-interventions avoided or similar? Low risk
Compliance acceptable? Low risk
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Zigler 2007 (Continued)
Timing of outcome assessments similar? Low risk
AE: adverse effects
BMI: body mass index
CT: computed tomography
DDD: degenerative disc disease
EQD: Euroqol
HNP: herniated nucleus pulposus
LBP: low-back pain
mo: month
MRI: magnetic resonance imaging
ODI: Oswestry Disability Index
RA: rheumatoid arthritis
RCT: randomised controlled trial
ROM: range of motion
SF: short form
VAS: visual analogue scale
vs versus
w/wo: with/without
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Cakir 2006 Non-randomized; specifically defined different selection criteria for the two interventions and this consequently
resulted in two different groups with associated distinct age categories
SariAli 2006 No clinical data.
Schroven 2006 Non-randomized.
Shim 2007 Retrospective; comparison between disc arthroplasties.
Tournier 2007 No clinical data.
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Characteristics of ongoing studies [ordered by study ID]
Aesculap Impl syst 2007
Trial name or title Clinical Study to Evaluate the Safety and Effectiveness of the Aesculap Activ-L Artificial Disc in the Treatment
of Degenerative Disc Disease
Methods Allocation: Randomized
Control: Active Control
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Participants Degenerative Disc Disease
Interventions Device: Activ-L Artificial Disc
Device: ProDisc Total Disc Replacement or Charite Atifical Disc
Outcomes Primary Outcome Measures: Improvement of at least 15 points in the Oswestry Disability Index score at 24
months compared to baseline [ Time Frame: 24 months ]
Secondary OutcomeMeasures: Back Pain, measured at rest using a visual analogue scale (VAS); improvement
of 20 mm or more on a 100 mm VAS scale at 24 months compared to baseline [ Time Frame: 24 months ]
Starting date January 2007
Contact information
Notes
Axiomed Spine Corp 2008
Trial name or title An IDE Study of the Freedom Lumbar Disc in the Treatment of Lumbar Degenerative Disc Disease
Methods Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Participants Degenerative Disc Disease (DDD)
Interventions Device: FLD
Device: Control
Outcomes Primary OutcomeMeasures: Overall success will be determined by a composite of measures regarding subject
self-assessment of function (disability), low-back pain, neurological function and device implantation status.
[ Time Frame: 24 Months ] [ Designated as safety issue: Yes ]
Secondary OutcomeMeasures: The improvement of subject self-assessment of function (disability), low-back
pain, patient satisfaction, neurological function and device implantation status at the 24 month follow-up
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Axiomed Spine Corp 2008 (Continued)
compared to baseline. [ Time Frame: 24 Months ] [ Designated as safety issue: Yes ]
Starting date September 2008
Contact information
Notes
Pioneer 2009b
Trial name or title A Prospective, Multi-center, Randomized, Controlled Clinical Trial Evaluating the Safety and Effectiveness
of NUBAC Disc Arthroplasty
Methods Allocation: Randomized
Control: Active Control
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Participants Degenerative Disc Disease
Interventions Device: NUBAC
Device: Prodisc
Outcomes Primary OutcomeMeasures: Improved patient function [ Time Frame: 6 weeks, 3, 6, 12, 24months, annually
thereafter ]
Starting date February 2009
Contact information
Notes
SpinalMotion 2006
Trial name or title Clinical Study Protocol for the Investigation of the Kineflex Spinal System - a Pivotal Study in Continued
Access Stage
Methods Allocation: Randomized
Control: Active Control
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Participants Degenerative Disc Disease
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SpinalMotion 2006 (Continued)
Interventions Device: Lumbar Artificial Disc
Device: Charite Artificial Disc
Outcomes Primary Outcome Measures: Improvement in Oswestry Low-Back Pain Disability Score at 24 months com-
pared with baseline; no revision removal, supplemental fixation or device-related re-operations and no major
adverse event as defined by the study protocol [ Time Frame: 24 months ] [ Designated as safety issue: Yes ]
Secondary Outcome Measures: Maintenance or improvement in neurologic status [ Time Frame: 24 months
] [ Designated as safety issue: Yes ]
Pain improvement [ Time Frame: 24 months ]
Significant disc height increase [ Time Frame: 24 months ]
No displacement or migration of the device [ Time Frame: 24 months ]
Time to return to work [ Time Frame: 24 months ]
Time to recovery [ Time Frame: 24 months ]
Preservation of at least 4 degrees of motion in flexion/extension [ Time Frame: 24 months ]
Starting date January 2005
Contact information
Notes
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D A T A A N D A N A L Y S E S
Comparison 1. Disc replacement versus fusion
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Back pain at 6 Months 2 706 Mean Difference (IV, Random, 95% CI) -6.44 [-10.55, -2.34]
2 Back pain at 24 Months 2 676 Mean Difference (IV, Random, 95% CI) -5.12 [-9.60, -0.64]
3 Improvement in back pain at 24
months
2 676 Mean Difference (IV, Random, 95% CI) 5.22 [0.18, 10.26]
4 Leg pain at 24 Months 1 524 Mean Difference (IV, Random, 95% CI) -3.60 [-8.84, 1.64]
5 Improvement in leg pain at 24
Months
2 676 Mean Difference (IV, Random, 95% CI) 0.56 [-4.54, 5.65]
6 Pain at 6 months 1 275 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
7 Pain at 24 months 2 500 Mean Difference (IV, Random, 95% CI) -6.16 [-11.98, -0.35]
8 Improvement in pain at 24
months
3 532 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
9 Overall improvement 4 Odds Ratio (M-H, Random, 95% CI) Totals not selected
10 Patient satisfaction 4 958 Odds Ratio (M-H, Random, 95% CI) 1.93 [1.36, 2.76]
11 Oswestry at 6 Months 2 309 Mean Difference (IV, Random, 95% CI) -9.90 [-14.31, -5.49]
12 Oswestry at 24 Months 5 1207 Mean Difference (IV, Random, 95% CI) -6.31 [-9.68, -2.94]
13 Improvement in Oswestry
score at 24 months
5 1207 Mean Difference (IV, Random, 95% CI) 4.27 [1.85, 6.68]
14 Percentage of patients improved
on Oswestry at 24 months
5 1244 Odds Ratio (M-H, Random, 95% CI) 1.45 [1.06, 1.98]
15 Improvement in working status
at 24 months
4 1188 Odds Ratio (M-H, Random, 95% CI) 1.02 [0.66, 1.59]
16 Implant motion 2 653 Mean Difference (IV, Random, 95% CI) 8.3 [7.02, 9.58]
17 Blood loss 5 1301 Mean Difference (IV, Random, 95% CI) -37.22 [-185.06,
110.62]
18 Reoperations 5 1194 Odds Ratio (M-H, Random, 95% CI) 0.80 [0.51, 1.24]
19 Adjacent segment degeneration 1 152 Odds Ratio (M-H, Random, 95% CI) 0.14 [0.02, 1.19]
20 Facet joint degeneration 1 152 Odds Ratio (M-H, Random, 95% CI) 12.65 [0.70, 228.67]
21 Radiographic loosening
(radiolucency)
1 236 Odds Ratio (M-H, Random, 95% CI) 0.15 [0.01, 3.82]
22 Subsidence 3 912 Odds Ratio (M-H, Random, 95% CI) 0.38 [0.18, 0.79]
Comparison 2. Disc arthroplasty versus rehabilitation
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Back Pain at 12 months 1 172 Mean Difference (IV, Random, 95% CI) -17.6 [-26.12, -9.08]
2 Back Pain at 24 months 1 172 Mean Difference (IV, Random, 95% CI) -14.30 [-22.89, -5.
71]
3 Oswestry at 12 months 1 172 Mean Difference (IV, Random, 95% CI) -8.90 [-13.03, -4.77]
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4 Oswestry at 24 months 1 172 Mean Difference (IV, Random, 95% CI) -6.90 [-11.57, -2.23]
5 Patient satisfaction 1 172 Odds Ratio (M-H, Random, 95% CI) 2.65 [1.42, 4.96]
6 Improvement in working status 1 172 Risk Ratio (M-H, Random, 95% CI) 0.92 [0.78, 1.07]
7 Reoperations 1 157 Odds Ratio (M-H, Random, 95% CI) 1.04 [0.29, 3.75]
Analysis 1.1. Comparison 1 Disc replacement versus fusion, Outcome 1 Back pain at 6 Months.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 1 Back pain at 6 Months
Study or subgroup Disc replacement Fusion
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Berg 2009 80 25.5 (26.5) 72 33.4 (26.8) 23.4 % -7.90 [ -16.39, 0.59 ]
Gornet 2011 391 18.1 (24) 163 24.1 (26.3) 76.6 % -6.00 [ -10.69, -1.31 ]
Total (95% CI) 471 235 100.0 % -6.44 [ -10.55, -2.34 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.15, df = 1 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 3.08 (P = 0.0021)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours Disc replacement Favours Fusion
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Analysis 1.2. Comparison 1 Disc replacement versus fusion, Outcome 2 Back pain at 24 Months.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 2 Back pain at 24 Months
Study or subgroup Disc arthroplasty Fusion
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Berg 2009 80 25.4 (29.8) 72 29.2 (24.6) 26.8 % -3.80 [ -12.46, 4.86 ]
Gornet 2011 379 18 (26.4) 145 23.6 (27.7) 73.2 % -5.60 [ -10.83, -0.37 ]
Total (95% CI) 459 217 100.0 % -5.12 [ -9.60, -0.64 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.12, df = 1 (P = 0.73); I2 =0.0%
Test for overall effect: Z = 2.24 (P = 0.025)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
Favours Disc arthroplasty Favours Fusion
Analysis 1.3. Comparison 1 Disc replacement versus fusion, Outcome 3 Improvement in back pain at 24
months.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 3 Improvement in back pain at 24 months
Study or subgroup Disc replacement Fusion
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Berg 2009 80 36.9 (31) 72 29.3 (31.6) 25.5 % 7.60 [ -2.37, 17.57 ]
Gornet 2011 379 53.4 (29.2) 145 49 (31) 74.5 % 4.40 [ -1.44, 10.24 ]
Total (95% CI) 459 217 100.0 % 5.22 [ 0.18, 10.26 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.29, df = 1 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 2.03 (P = 0.042)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
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Analysis 1.4. Comparison 1 Disc replacement versus fusion, Outcome 4 Leg pain at 24 Months.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 4 Leg pain at 24 Months
Study or subgroup Disc replacement Fusion
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Gornet 2011 379 15.9 (25.6) 145 19.5 (28) 100.0 % -3.60 [ -8.84, 1.64 ]
Total (95% CI) 379 145 100.0 % -3.60 [ -8.84, 1.64 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.35 (P = 0.18)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours Disc replacement Favours Fusion
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Analysis 1.5. Comparison 1 Disc replacement versus fusion, Outcome 5 Improvement in leg pain at 24
Months.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 5 Improvement in leg pain at 24 Months
Study or subgroup Disc replacement Fusion
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Berg 2009 80 21 (26.4) 72 23.2 (28.1) 34.4 % -2.20 [ -10.89, 6.49 ]
Gornet 2011 379 27.2 (35.3) 145 25.2 (31.9) 65.6 % 2.00 [ -4.29, 8.29 ]
Total (95% CI) 459 217 100.0 % 0.56 [ -4.54, 5.65 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.59, df = 1 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 0.21 (P = 0.83)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours Fusion Favours Disc replacement
Analysis 1.6. Comparison 1 Disc replacement versus fusion, Outcome 6 Pain at 6 months.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 6 Pain at 6 months
Study or subgroup Disc arthroplasty Fusion
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Blumenthal 2005 188 33.1 (0) 87 43.9 (0) 0.0 [ 0.0, 0.0 ]
Total (95% CI) 188 87 0.0 [ 0.0, 0.0 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours disc replacement Favours fusion
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Analysis 1.7. Comparison 1 Disc replacement versus fusion, Outcome 7 Pain at 24 months.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 7 Pain at 24 months
Study or subgroup Disc replacement Fusion
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Blumenthal 2005 (1) 186 31.2 (30.3) 82 37.5 (30.3) 54.6 % -6.30 [ -14.17, 1.57 ]
Zigler 2007 159 37 (30.1) 73 43 (31.6) 45.4 % -6.00 [ -14.63, 2.63 ]
Total (95% CI) 345 155 100.0 % -6.16 [ -11.98, -0.35 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 2.08 (P = 0.038)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
Favours disc replacement Favours fusion
(1) SD Blumental imputed from Zigler
Analysis 1.8. Comparison 1 Disc replacement versus fusion, Outcome 8 Improvement in pain at 24 months.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 8 Improvement in pain at 24 months
Study or subgroup Disc replacement Fusion
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Blumenthal 2005 186 41.8 (0) 82 34.3 (0) 0.0 [ 0.0, 0.0 ]
Moreno 2008 14 63.2 (0) 18 63.2 (0) 0.0 [ 0.0, 0.0 ]
Zigler 2007 159 39 (0) 73 32 (0) 0.0 [ 0.0, 0.0 ]
Total (95% CI) 359 173 0.0 [ 0.0, 0.0 ]
Heterogeneity: Tau2 = ; Chi2 = 0.0, df = 0 (P<0.00001); I2 =0.0%
Test for overall effect: Z = 0.0 (P < 0.00001)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
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Analysis 1.9. Comparison 1 Disc replacement versus fusion, Outcome 9 Overall improvement.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 9 Overall improvement
Study or subgroup Disc replacement Fusion
Odds
Ratio(Non-
event)
Odds
Ratio(Non-
event)
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Blumenthal 2005 117/205 46/99 0.65 [ 0.40, 1.06 ]
Gornet 2011 230/313 57/103 0.45 [ 0.28, 0.71 ]
Moreno 2008 11/14 10/18 0.34 [ 0.07, 1.65 ]
Zigler 2007 78/147 27/66 0.61 [ 0.34, 1.10 ]
0.01 0.1 1 10 100
Favours Disc replacement Favours fusion
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Analysis 1.10. Comparison 1 Disc replacement versus fusion, Outcome 10 Patient satisfaction.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 10 Patient satisfaction
Study or subgroup Disc replacement Fusion Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Berg 2009 (1) 57/80 48/72 23.2 % 1.24 [ 0.62, 2.47 ]
Blumenthal 2005 (2) 130/176 39/74 32.4 % 2.54 [ 1.44, 4.47 ]
Gornet 2011 (3) 330/379 110/145 41.6 % 2.14 [ 1.32, 3.48 ]
Moreno 2008 (4) 12/14 16/18 2.8 % 0.75 [ 0.09, 6.11 ]
Total (95% CI) 649 309 100.0 % 1.93 [ 1.36, 2.76 ]
Total events: 529 (Disc replacement), 213 (Fusion)
Heterogeneity: Tau2 = 0.02; Chi2 = 3.43, df = 3 (P = 0.33); I2 =13%
Test for overall effect: Z = 3.64 (P = 0.00027)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours fusion Favours disc replacement
(1) Satisfied with the treatment
(2) Would have same treatment again
(3) Satisfied
(4) Would you recommend?
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Analysis 1.11. Comparison 1 Disc replacement versus fusion, Outcome 11 Oswestry at 6 Months.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 11 Oswestry at 6 Months
Study or subgroup Disc replacement Fusion
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Blumenthal 2005 189 27.5 (0) 88 35.8 (0) 0.0 [ 0.0, 0.0 ]
Moreno 2008 14 18.2 (5.32) 18 28.1 (7.4) -9.90 [ -14.31, -5.49 ]
Total (95% CI) 203 106 -9.90 [ -14.31, -5.49 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 4.40 (P = 0.000011)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
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Analysis 1.12. Comparison 1 Disc replacement versus fusion, Outcome 12 Oswestry at 24 Months.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 12 Oswestry at 24 Months
Study or subgroup Disc replacement Fusion
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Berg 2009 80 20 (19.6) 72 23 (17) -3.00 [ -8.82, 2.82 ]
Blumenthal 2005 185 26.3 (0) 82 30.5 (0) 0.0 [ 0.0, 0.0 ]
Gornet 2011 379 19.4 (20.2) 145 24.8 (19.6) -5.40 [ -9.18, -1.62 ]
Moreno 2008 (1) 14 26.7 (8.4) 18 38 (6.5) -11.30 [ -16.63, -5.97 ]
Zigler 2007 159 34.5 (24.8) 73 39.8 (24.3) -5.30 [ -12.08, 1.48 ]
Total (95% CI) 817 390 -6.31 [ -9.68, -2.94 ]
Heterogeneity: Tau2 = 4.60; Chi2 = 4.92, df = 3 (P = 0.18); I2 =39%
Test for overall effect: Z = 3.67 (P = 0.00024)
Test for subgroup differences: Not applicable
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(1) Scores converted from a 60 point scale
Analysis 1.13. Comparison 1 Disc replacement versus fusion, Outcome 13 Improvement in Oswestry score
at 24 months.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 13 Improvement in Oswestry score at 24 months
Study or subgroup Disc replacement Fusion
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Berg 2009 80 21.9 (18.9) 72 18.2 (18) 17.0 % 3.70 [ -2.17, 9.57 ]
Blumenthal 2005 185 24.3 (20.2) 82 21.6 (20.2) 21.2 % 2.70 [ -2.55, 7.95 ]
Gornet 2011 379 33.8 (21.1) 145 29.2 (19.4) 40.3 % 4.60 [ 0.79, 8.41 ]
Moreno 2008 14 16.7 (20.2) 18 13.4 (20.2) 2.9 % 3.30 [ -10.81, 17.41 ]
Zigler 2007 (1) 159 28.9 (20.2) 73 22.9 (20.2) 18.6 % 6.00 [ 0.40, 11.60 ]
Total (95% CI) 817 390 100.0 % 4.27 [ 1.85, 6.68 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.79, df = 4 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 3.46 (P = 0.00054)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
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(1) Statistical significance differs from publication, probably due to multiple testing correction in the paper.
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Analysis 1.14. Comparison 1 Disc replacement versus fusion, Outcome 14 Percentage of patients improved
on Oswestry at 24 months.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 14 Percentage of patients improved on Oswestry at 24 months
Study or subgroup Disc replacement Fusion Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Berg 2009 (1) 25/80 28/72 17.1 % 0.71 [ 0.37, 1.39 ]
Blumenthal 2005 (2) 131/205 50/99 27.1 % 1.73 [ 1.07, 2.82 ]
Gornet 2011 (3) 312/379 108/145 29.3 % 1.60 [ 1.01, 2.52 ]
Moreno 2008 (4) 7/14 7/18 4.6 % 1.57 [ 0.38, 6.45 ]
Zigler 2007 (5) 108/159 40/73 21.9 % 1.75 [ 0.99, 3.09 ]
Total (95% CI) 837 407 100.0 % 1.45 [ 1.06, 1.98 ]
Total events: 583 (Disc replacement), 233 (Fusion)
Heterogeneity: Tau2 = 0.03; Chi2 = 5.40, df = 4 (P = 0.25); I2 =26%
Test for overall effect: Z = 2.32 (P = 0.020)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours fusion Favours disc replacement
(1) 25% improvement
(2) 25% improvement
(3) 30% improvement
(4) 50% improvement
(5) 30% improvement
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Analysis 1.15. Comparison 1 Disc replacement versus fusion, Outcome 15 Improvement in working status
at 24 months.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 15 Improvement in working status at 24 months
Study or subgroup Disc replacement Fusion
Odds
Ratio(Non-
event) Weight
Odds
Ratio(Non-
event)
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Berg 2009 6/80 2/72 7.1 % 0.35 [ 0.07, 1.80 ]
Blumenthal 2005 17/188 7/88 21.2 % 0.87 [ 0.35, 2.18 ]
Gornet 2011 50/379 25/145 55.5 % 1.37 [ 0.81, 2.31 ]
Zigler 2007 14/161 5/75 16.2 % 0.75 [ 0.26, 2.16 ]
Total (95% CI) 808 380 100.0 % 1.02 [ 0.66, 1.59 ]
Total events: 87 (Disc replacement), 39 (Fusion)
Heterogeneity: Tau2 = 0.02; Chi2 = 3.27, df = 3 (P = 0.35); I2 =8%
Test for overall effect: Z = 0.11 (P = 0.91)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours disc replacement Favours fusion
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Analysis 1.16. Comparison 1 Disc replacement versus fusion, Outcome 16 Implant motion.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 16 Implant motion
Study or subgroup Disc replacement Fusion
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Berg 2009 68 9 (4.7) 61 0.7 (2.5) 8.30 [ 7.02, 9.58 ]
Gornet 2011 (1) 379 9.5 (0) 145 0.6 (0) 0.0 [ 0.0, 0.0 ]
Total (95% CI) 447 206 8.30 [ 7.02, 9.58 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 12.70 (P < 0.00001)
Test for subgroup differences: Not applicable
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(1) at 24 months
Analysis 1.17. Comparison 1 Disc replacement versus fusion, Outcome 17 Blood loss.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 17 Blood loss
Study or subgroup Disc replacement Fusion
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Berg 2009 (1) 80 450 (447) 72 400 (404) 18.9 % 50.00 [ -85.29, 185.29 ]
Blumenthal 2005 205 205 (211.7) 99 208.9 (283.9) 21.6 % -3.90 [ -66.89, 59.09 ]
Gornet 2011 405 240.7 (301.1) 172 95.2 (106.9) 22.2 % 145.50 [ 112.11, 178.89 ]
Moreno 2008 (2) 14 150 (188) 18 300 (317) 17.0 % -150.00 [ -326.48, 26.48 ]
Zigler 2007 161 204 (231.3) 75 465 (440) 20.2 % -261.00 [ -366.80, -155.20 ]
Total (95% CI) 865 436 100.0 % -37.22 [ -185.06, 110.62 ]
Heterogeneity: Tau2 = 25289.12; Chi2 = 68.21, df = 4 (P<0.00001); I2 =94%
Test for overall effect: Z = 0.49 (P = 0.62)
Test for subgroup differences: Not applicable
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(1) SD estimated from trendline found from mean and SD in the three other studies
(2) SD estimated from trendline found from mean and SD in the three other studies
Analysis 1.18. Comparison 1 Disc replacement versus fusion, Outcome 18 Reoperations.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 18 Reoperations
Study or subgroup Disc replacement Fusion Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Berg 2009 8/80 7/72 1.03 [ 0.35, 3.00 ]
Blumenthal 2005 (1) 11/176 9/74 0.48 [ 0.19, 1.22 ]
Gornet 2011 (2) 38/379 17/145 0.84 [ 0.46, 1.54 ]
Moreno 2008 0/14 0/18 0.0 [ 0.0, 0.0 ]
Zigler 2007 (3) 6/161 2/75 1.41 [ 0.28, 7.17 ]
Total (95% CI) 810 384 0.80 [ 0.51, 1.24 ]
Total events: 63 (Disc replacement), 35 (Fusion)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.87, df = 3 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 1.01 (P = 0.31)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours disc replacement Favours fusion
(1) Revision, reoperation, removals up to 24 monts; N excluding loss to follow up and deaths
(2) Revisions (0 VS 0), removals (2 VS 0), supplementary fixations (15 vs 14) and reoperations (22 vs 3) up to 24 months
(3) Up to 24 months; excluding screw removals (2)
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Analysis 1.19. Comparison 1 Disc replacement versus fusion, Outcome 19 Adjacent segment degeneration.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 19 Adjacent segment degeneration
Study or subgroup Disc replacement Fusion Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Berg 2009 (1) 1/80 6/72 100.0 % 0.14 [ 0.02, 1.19 ]
Total (95% CI) 80 72 100.0 % 0.14 [ 0.02, 1.19 ]
Total events: 1 (Disc replacement), 6 (Fusion)
Heterogeneity: not applicable
Test for overall effect: Z = 1.80 (P = 0.071)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours disc replacement Favours fusion
(1) up to 24 months
Analysis 1.20. Comparison 1 Disc replacement versus fusion, Outcome 20 Facet joint degeneration.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 20 Facet joint degeneration
Study or subgroup Disc replacement Fusion Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Berg 2009 (1) 6/80 0/72 100.0 % 12.65 [ 0.70, 228.67 ]
Total (95% CI) 80 72 100.0 % 12.65 [ 0.70, 228.67 ]
Total events: 6 (Disc replacement), 0 (Fusion)
Heterogeneity: not applicable
Test for overall effect: Z = 1.72 (P = 0.086)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours disc replacement Favours fusion
(1) up to 24 months
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Analysis 1.21. Comparison 1 Disc replacement versus fusion, Outcome 21 Radiographic loosening
(radiolucency).
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 21 Radiographic loosening (radiolucency)
Study or subgroup Disc replacement Fusion Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Zigler 2007 0/161 1/75 100.0 % 0.15 [ 0.01, 3.82 ]
Total (95% CI) 161 75 100.0 % 0.15 [ 0.01, 3.82 ]
Total events: 0 (Disc replacement), 1 (Fusion)
Heterogeneity: not applicable
Test for overall effect: Z = 1.14 (P = 0.25)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours disc replacement Favours fusion
Analysis 1.22. Comparison 1 Disc replacement versus fusion, Outcome 22 Subsidence.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 1 Disc replacement versus fusion
Outcome: 22 Subsidence
Study or subgroup Disc replacement Fusion Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Berg 2009 1/80 0/72 5.2 % 2.74 [ 0.11, 68.23 ]
Gornet 2011 13/379 14/145 87.9 % 0.33 [ 0.15, 0.73 ]
Zigler 2007 (1) 1/161 1/75 6.9 % 0.46 [ 0.03, 7.50 ]
Total (95% CI) 620 292 100.0 % 0.38 [ 0.18, 0.79 ]
Total events: 15 (Disc replacement), 15 (Fusion)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.60, df = 2 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 2.60 (P = 0.0094)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours disc replacement Favours fusion
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(1) At 24 Months, not clinically signiicant
Analysis 2.1. Comparison 2 Disc arthroplasty versus rehabilitation, Outcome 1 Back Pain at 12 months.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 2 Disc arthroplasty versus rehabilitation
Outcome: 1 Back Pain at 12 months
Study or subgroup Disc arthroplasty Rehabilitation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Hellum 2011 86 35.6 (28.6) 86 53.2 (28.4) 100.0 % -17.60 [ -26.12, -9.08 ]
Total (95% CI) 86 86 100.0 % -17.60 [ -26.12, -9.08 ]
Heterogeneity: not applicable
Test for overall effect: Z = 4.05 (P = 0.000051)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours Disc arthroplasty Favours Rehabilitation
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Analysis 2.2. Comparison 2 Disc arthroplasty versus rehabilitation, Outcome 2 Back Pain at 24 months.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 2 Disc arthroplasty versus rehabilitation
Outcome: 2 Back Pain at 24 months
Study or subgroup Disc arthroplasty Rehabilitation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Hellum 2011 86 35.4 (29.1) 86 49.7 (28.4) 100.0 % -14.30 [ -22.89, -5.71 ]
Total (95% CI) 86 86 100.0 % -14.30 [ -22.89, -5.71 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.26 (P = 0.0011)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours Disc arthroplasty Favours Rehabilitation
Analysis 2.3. Comparison 2 Disc arthroplasty versus rehabilitation, Outcome 3 Oswestry at 12 months.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 2 Disc arthroplasty versus rehabilitation
Outcome: 3 Oswestry at 12 months
Study or subgroup Disc arthroplasty Rehabilitation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Hellum 2011 86 20.3 (17.2) 86 29.2 (9.3) 100.0 % -8.90 [ -13.03, -4.77 ]
Total (95% CI) 86 86 100.0 % -8.90 [ -13.03, -4.77 ]
Heterogeneity: not applicable
Test for overall effect: Z = 4.22 (P = 0.000024)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours Disc arthroplasty Favours Rehabilitation
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Analysis 2.4. Comparison 2 Disc arthroplasty versus rehabilitation, Outcome 4 Oswestry at 24 months.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 2 Disc arthroplasty versus rehabilitation
Outcome: 4 Oswestry at 24 months
Study or subgroup Disc arthroplasty Rehabilitation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Hellum 2011 (1) 86 19.8 (16.7) 86 26.7 (14.5) 100.0 % -6.90 [ -11.57, -2.23 ]
Total (95% CI) 86 86 100.0 % -6.90 [ -11.57, -2.23 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.89 (P = 0.0038)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours Disc arthroplasty Favours Rehabilitation
(1) ITT analysis
Analysis 2.5. Comparison 2 Disc arthroplasty versus rehabilitation, Outcome 5 Patient satisfaction.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 2 Disc arthroplasty versus rehabilitation
Outcome: 5 Patient satisfaction
Study or subgroup
Total disc
replace-
ment Rehabilitation Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Hellum 2011 46/86 26/86 100.0 % 2.65 [ 1.42, 4.96 ]
Total (95% CI) 86 86 100.0 % 2.65 [ 1.42, 4.96 ]
Total events: 46 (Total disc replacement), 26 (Rehabilitation)
Heterogeneity: not applicable
Test for overall effect: Z = 3.06 (P = 0.0022)
Test for subgroup differences: Not applicable
0.2 0.5 1 2 5
Favours rehabilitation Favours total disc replacement
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Analysis 2.6. Comparison 2 Disc arthroplasty versus rehabilitation, Outcome 6 Improvement in working
status.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 2 Disc arthroplasty versus rehabilitation
Outcome: 6 Improvement in working status
Study or subgroup Disc arthroplasty Rehabilitation
Risk
Ratio(Non-
event) Weight
Risk
Ratio(Non-
event)
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Hellum 2011 21/86 15/86 100.0 % 0.92 [ 0.78, 1.07 ]
Total (95% CI) 86 86 100.0 % 0.92 [ 0.78, 1.07 ]
Total events: 21 (Disc arthroplasty), 15 (Rehabilitation)
Heterogeneity: not applicable
Test for overall effect: Z = 1.12 (P = 0.26)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours Disc arthroplasty Favours Rehabilitation
Analysis 2.7. Comparison 2 Disc arthroplasty versus rehabilitation, Outcome 7 Reoperations.
Review: Total disc replacement for chronic back pain in the presence of disc degeneration
Comparison: 2 Disc arthroplasty versus rehabilitation
Outcome: 7 Reoperations
Study or subgroup Disc arthroplasty Rehabilitation Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Hellum 2011 5/77 5/80 100.0 % 1.04 [ 0.29, 3.75 ]
Total (95% CI) 77 80 100.0 % 1.04 [ 0.29, 3.75 ]
Total events: 5 (Disc arthroplasty), 5 (Rehabilitation)
Heterogeneity: not applicable
Test for overall effect: Z = 0.06 (P = 0.95)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours experimental Favours control
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A D D I T I O N A L T A B L E S
Table 1. Characteristics of (excluded) observational studies
Study Characteristic Remark
Cakir 2006 Selection bias Included spinal claudication patients specifically in the control group, but not in the experi-
mental group. Resulting age difference large
Population > 12 months LBP, > 6 months conservative therapy, no spondylolisthesis, no spondylosis, no
antero- or retrolisthesis, no facet joint arthritis
total disc replacement: DDD, One level
Control: Spinal Claudication
Interventions Total disc replacement: Prodisc
Control: Dynesis (Zimmer, Winterthur, Switzerland; pedicle screws, spacers and rods) with
decompression
Outcomes ODI, SF-36 @ preop and latest (15.3 and 21.8 months)
Remarks No difference between treatments discussed
Schroven 2006 Population DDD or lumbar spondylosis, CT/MRI confirmed
18-60 years
> 6 months of conservative therapy
No baseline characteristics given
Interventions total disc replacement: Prodisc
Control: ALIF (unknown cage with iliac crest autograft)
Allocation to groups not described
Outcomes ODI @ preoperative and 6, 12 months
Remarks Prodisc better ODI improvement that ALIF, also better in length of stay, blood loss and
operation time
Shim 2007 Design Retrospective comparison
Interventions Two disc replacement devices.
CT: computed tomography
DDD: degenerative disc disease
LBP: low-back pain
MRI: magnetic resonance imaging
ODI: Oswestry Disability Index
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Table 2. Clinical relevance
Item Berg 2009 Blumenthal
2005
Gornet 2011 Hellum 2011 Moreno 2008 Sasso 2008 Zigler 2007
1. Are the pa-
tients de-
scribed in de-
tail so that you
can decide
whether they
are compara-
ble to those
that you see in
your practice?
Yes Yes Yes Yes No No Yes
2. Are the in-
terventions
and treatment
settings
described well
enough so that
you can pro-
vide the same
for your pa-
tients?
Yes Yes Yes Yes Yes Yes Yes
3. Were all
clinically rele-
vant outcomes
measured and
reported?
Yes Yes Yes Yes No Yes Yes
4. Is the
size of the ef-
fect clinically
important?
No Yes No No No Unsure No
5. Are the
likely treat-
ment benefits
worth the po-
tential harms?
No Unsure No No No Unsure No
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A P P E N D I C E S
Appendix 1. Search strategies
MEDLINE
NB: MEDLINE strategy uses Cochrane Search Filter for RCTS plus BMJ Clinical evidence Cohort & case series filter
1. randomized controlled trial.pt.
2. controlled clinical trial.pt.
3. randomized.ab.
4. placebo.ab,ti.
5. drug therapy.fs.
6. randomly.ab,ti.
7. trial.ab,ti.
8. groups.ab,ti.
9. or/1-8
10. (animals not (humans and animals)).sh.
11. 9 not 10
12. Comparative Study/
13. exp Evaluation Studies/
14. exp Follow-Up Studies/
15. exp Prospective Studies/
16. exp Cross-Over Studies/
17. exp Epidemiologic Studies/
18. exp Case-Control Studies/
19. exp Cohort Studies/
20. exp Cross-Sectional Studies/
21. (cohort adj (study or studies)).mp
22. cohort analy$.mp
23. (follow up adj (study or studies)).mp.
24. (observational adj (study or studies)).mp.
25. longitudinal.mp.
26. retrospective.mp.
27. cross sectional.mp.
28. control$.mp.
29. prospective$.mp.
30. volunteer.mp.
31. or/12-30
32. 31 not 10
33. 32 or 11
34. exp Cohort Studies/
35. cohort$.tw.
36. controlled clinical trial.pt.
37. Epidemiologic Methods/
38. limit 37 to yr=1966-1989
39. exp Case-Control Studies/
40. (case$ and control$).tw.
41. (case$ and series).tw.
42. or/34-36,38-41
43. 42 not 10
44. 33 or 43
45. exp Spine/
46. exp Spinal Diseases/
47. exp Back Pain/
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48. exp Intervertebral Disk/
49. intervertebral disc.mp.
50. exp Intervertebral Disk Displacement/
51. exp Discitis/
52. dorsalgia.ti,ab.
53. backache.ti,ab.
54. spondylosis.ti,ab.
55. lumbago.ti,ab.
56. (lumbar adj pain).ti,ab.
57. sciatic neuropathy/
58. sciatica.ti,ab.
59. (disc adj degeneration).mp.
60. (spine or spinal).mp.
61. vertebra$.mp.
62. (disc or discs or disk or disks).mp.
63. or/45-62
64. ”Prostheses and Implants“/
65. Implants, Experimental/
66. Prosthesis Implantation/
67. Arthroplasty, Replacement/
68. exp Arthroplasty/ or arthroplasty.mp.
69. or/64-68
70. 62 and 69
71. disc replacement.mp.
72. kinematic.mp.
73. active L.mp.
74. charite.mp.
75. prodisc.mp.
76. kineflex.mp.
77. maverick.mp.
78. mobidisc.mp.
79. flexicore.mp.
80. nubac.mp.
81. acroflex.mp.
82. artificial.ti,ab.
83. flexible.ti,ab.
84. mobile.ti,ab.
85. kinematic.ti,ab.
86. prestige.mp.
87. (pro adj disc).mp.
88. porous coated motion.mp.
89. or/71-88
90. 62 and 89
91. 70 or 90
92. 44 and 63 and 91
EMBASE
1. Clinical Article/
2. exp Clinical Study/
3. Clinical Trial/
4. Controlled Study/
5. Randomized Controlled Trial/
6. Major Clinical Study/
7. Double Blind Procedure/
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8. Multicenter Study/
9. Single Blind Procedure/
10. Phase 3 Clinical Trial/
11. Phase 4 Clinical Trial/
12. crossover procedure/
13. placebo/
14. or/1-13
15. allocat$.mp.
16. assign$.mp.
17. blind$.mp.
18. (clinic$ adj25 (study or trial)).mp.
19. compar$.mp.
20. control$.mp.
21. cross?over.mp.
22. factorial$.mp.
23. follow?up.mp.
24. placebo$.mp.
25. prospectiv$.mp.
26. random$.mp.
27. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).mp.
28. trial.mp.
29. (versus or vs).mp.
30. or/15-29
31. 14 and 30
32. human/
33. Nonhuman/
34. exp ANIMAL/
35. Animal Experiment/
36. 33 or 34 or 35
37. 32 not 36
38. 31 not 36
39. 37 and 38
40. exp SPINE/
41. exp Spine Disease/
42. exp Backache/
43. exp Intervertebral Disk/
44. intervertebral disc.mp.
45. exp Intervertebral Disk Hernia/
46. exp Diskitis/
47. exp LOW BACK PAIN/
48. (lumbar adj pain).mp.
49. exp ISCHIALGIA/
50. spondylosis.mp.
51. lumbago.mp.
52. sciatica.mp.
53. back pain.mp.
54. dorsalgia.mp.
55. discitis.mp.
56. (disc adj degeneration).mp.
57. (disk adj degeneration).mp.
58. vertebra$.mp.
59. (disc or discs or disk or disks).mp.
60. exp Intervertebral Disk Degeneration/
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61. or/40-60
62. prestige.mp.
63. porous coated motion.mp.
64. prodisc.mp.
65. exp PROSTHESIS/
66. exp IMPLANT/
67. exp Implantation/
68. exp ARTHROPLASTY/
69. exp Intervertebral Diskectomy/
70. kinematic.mp. or exp KINEMATICS/
71. Active L.mp.
72. charite.mp.
73. kineflex.mp.
74. maverick.mp.
75. mobidisc.mp.
76. flexicore.mp.
77. nubac.mp.
78. acroflex.mp.
79. artificial.ti,ab.
80. flexible.ti,ab.
81. kinematic.ti,ab.
82. or/62-81
83. 59 and 82
84. 39 and 61 and 83
BIOSIS
NB: strategy uses the RCT filter developed by Lisa Tjosvold Sept. 2, 2003 for the Child Health Field.
#24 #23 AND #16
#23 #22 OR #21 OR #20 OR #19 OR #18 OR #17
#22 TS=(disc OR disk) AND TS=(replacement OR kinematic OR artificial OR flexible OR mobile OR Active L OR charite OR
Maverick)
#21 Topic=(flexicore)
#20 Topic=(Arthroplasty)
#19 Topic=(porous coated motion)
#18 Topic=(prodisc)
#17 Topic=(prestige)
#16 #15 AND #1
#15 #14 OR #13 OR #12 OR #11 OR #10 OR #9 OR #8 OR #7 OR #6 OR #5 OR #4 OR #3 OR #2
#14 Topic=(lumbar vertebra*)
#13 Topic=(disc) OR Topic=(discs) OR Topic=(disk) OR Topic=(disks)
#12 Topic=(sciatica)
#11 Topic=(lumbago)
#10 Topic=(spondylosis)
#9 Topic=(backache)
#8 Topic=(dorsalgia)
#7 Topic=(dis*itis)
#6 TS=intervertebral dis*
#5 Topic=(”low back pain“)
#4 Topic=(”back pain“)
#3 Topic=(back pain)
#2 Topic=(spine) OR Topic=(spinal)
#1 TS= clinical trial* OR TS=research design OR TS=comparative stud* OR TS=evaluation stud* OR TS=controlled trial* OR TS=
follow-up stud* OR TS=prospective stud* OR TS=random* OR TS=placebo* OR TS=(single blind*) OR TS=(double blind*)
CENTRAL
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#1 MeSH descriptor Back Pain explode all trees
#2 dorsalgia
#3 backache
#4 MeSH descriptor Low Back Pain explode all trees
#5 (lumbar next pain) or (coccyx) or (coccydynia) or (sciatica) or (spondylosis)
#6 MeSH descriptor Sciatica explode all trees
#7 MeSH descriptor Spine explode all trees
#8 MeSH descriptor Spinal Diseases explode all trees
#9 (lumbago) or (discitis) or (disc near degeneration) or (disc near prolapse) or (disc near herniation)
#10 spinal fusion
#11 facet near joints
#12 MeSH descriptor Intervertebral Disk explode all trees
#13 postlaminectomy
#14 arachnoiditis
#15 failed near back
#16 MeSH descriptor Cauda Equina explode all trees
#17 lumbar near vertebra*
#18 spinal near stenosis
#19 slipped near (disc* or disk*)
#20 degenerat* near (disc* or disk*)
#21 stenosis near (spine or root or spinal)
#22 displace* near (disc* or disk*)
#23 prolap* near (disc* or disk*)
#24 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16
OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23)
#25 MeSH descriptor Prostheses and Implants, this term only
#26 MeSH descriptor Prosthesis Implantation, this term only
#27 MeSH descriptor Implants, Experimental, this term only
#28 MeSH descriptor Arthroplasty explode all trees
#29 MeSH descriptor Arthroplasty, Replacement, this term only
#30 arthroplasty
#31 disc replacement
#32 prestige
#33 prodisc
#34 porous coated motion
#35 kinematic NEAR disc
#36 kinematic
#37 (#25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36)
#38 disc or dics or disk or disks
#39 (#37 AND #38)
#40 (#24 AND #39)
Appendix 2. Criteria and operationalisation for ’Risk of bias’ assessment
Random sequence generation (selection bias)
Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence
There is a low risk of selection bias if the investigators describe a random component in the sequence generation process such as: referring
to a random number table, using a computer random number generator, coin tossing, shuffling cards or envelopes, throwing dice,
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drawing of lots, minimisation (minimisation may be implemented without a random element, and this is considered to be equivalent
to being random).
There is a high risk of selection bias if the investigators describe a non-random component in the sequence generation process, such as:
sequence generated by odd or even date of birth, date (or day) of admission, hospital or clinic record number; or allocation by judgment
of the clinician, preference of the participant, results of a laboratory test or a series of tests, or availability of the intervention.
Allocation concealment (selection bias)
Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment
There is a low risk of selection bias if the participants and investigators enrolling participants could not foresee assignment because
one of the following, or an equivalent method, was used to conceal allocation: central allocation (including telephone, web-based
and pharmacy-controlled randomisation); sequentially numbered drug containers of identical appearance; or sequentially numbered,
opaque, sealed envelopes.
There is a high risk of bias if participants or investigators enrolling participants could possibly foresee assignments and thus introduce
selection bias, such as allocation based on: using an open random allocation schedule (e.g. a list of random numbers); assignment
envelopes were used without appropriate safeguards (e.g. if envelopes were unsealed or non-opaque or not sequentially numbered);
alternation or rotation; date of birth; case record number; or other explicitly unconcealed procedures.
Blinding of participants
Performance bias due to knowledge of the allocated interventions by participants during the study
There is a low risk of performance bias if blinding of participants was ensured and it was unlikely that the blinding could have been
broken; or if there was no blinding or incomplete blinding, but the review authors judge that the outcome is not likely to be influenced
by lack of blinding.
Blinding of personnel/care providers (performance bias)
Performance bias due to knowledge of the allocated interventions by personnel/care providers during the study
There is a low risk of performance bias if blinding of personnel was ensured and it was unlikely that the blinding could have been
broken; or if there was no blinding or incomplete blinding, but the review authors judge that the outcome is not likely to be influenced
by lack of blinding.
Blinding of outcome assessor (detection bias)
Detection bias due to knowledge of the allocated interventions by outcome assessors
There is low risk of detection bias if the blinding of the outcome assessment was ensured and it was unlikely that the blinding could
have been broken; or if there was no blinding or incomplete blinding, but the review authors judge that the outcome is not likely to
be influenced by lack of blinding, or:
• for patient-reported outcomes in which the patient was the outcome assessor (e.g. pain, disability): there is a low risk of bias for
outcome assessors if there is a low risk of bias for participant blinding (Boutron 2005); for outcome criteria that are clinical or
therapeutic events that will be determined by the interaction between patients and care providers (e.g. co-interventions, length of
hospitalisation, treatment failure), in which the care provider is the outcome assessor: there is a low risk of bias for outcome assessors if
there is a low risk of bias for care providers (Boutron 2005); for outcome criteria that are assessed from data from medical forms: there
is a low risk of bias if the treatment or adverse effects of the treatment could not be noticed in the extracted data (Boutron 2005).
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Incomplete outcome data (attrition bias)
Attrition bias due to amount, nature or handling of incomplete outcome data
There is a low risk of attrition bias if there were no missing outcome data; reasons for missing outcome data were unlikely to be related
to the true outcome (for survival data, censoring unlikely to be introducing bias); missing outcome data were balanced in numbers,
with similar reasons for missing data across groups; for dichotomous outcome data, the proportion of missing outcomes compared
with the observed event risk was not enough to have a clinically relevant impact on the intervention effect estimate; for continuous
outcome data, the plausible effect size (difference in means or standardised difference in means) among missing outcomes was not
enough to have a clinically relevant impact on observed effect size, or missing data were imputed using appropriate methods (if drop-
outs are very large, imputation using even ’acceptable’ methods may still suggest a high risk of bias) (Van Tulder 2003). The percentage
of withdrawals and drop-outs should not exceed 20% for short-term follow-up and 30% for long-term follow-up and should not lead
to substantial bias (these percentages are commonly used but arbitrary, not supported by literature) (Van Tulder 2003).
Selective reporting (reporting bias)
Reporting bias due to selective outcome reporting
There is low risk of reporting bias if the study protocol is available and all of the study’s pre-specified (primary and secondary) outcomes
that are of interest in the review have been reported in the pre-specified way, or if the study protocol is not available but it is clear that
the published reports include all expected outcomes, including those that were pre-specified (convincing text of this nature may be
uncommon).
There is a high risk of reporting bias if not all of the study’s pre-specified primary outcomes have been reported; one or more primary
outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not pre-specified; one or
more reported primary outcomes were not pre-specified (unless clear justification for their reporting is provided, such as an unexpected
adverse effect); one or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-
analysis; the study report fails to include results for a key outcome that would be expected to have been reported for such a study.
Group similarity at baseline (selection bias)
Bias due to dissimilarity at baseline for the most important prognostic indicators.
There is low risk of bias if groups are similar at baseline for demographic factors, value of main outcome measure(s), and important
prognostic factors (examples in the field of back and neck pain are duration and severity of complaints, vocational status, percentage
of patients with neurological symptoms) (Van Tulder 2003).
Co-interventions (performance bias)
Bias because co-interventions were different across groups
There is low risk of bias if there were no co-interventions or they were similar between the index and control groups (Van Tulder 2003).
Compliance (performance bias)
Bias due to inappropriate compliance with interventions across groups
There is low risk of bias if compliance with the interventions was acceptable, based on the reported intensity/dosage, duration, number
and frequency for both the index and control intervention(s). For single-session interventions (e.g. surgery), this item is irrelevant (Van
Tulder 2003).
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Intention-to-treat-analysis
There is low risk of bias if all randomized patients were reported/analysed in the group to which they were allocated by randomisation.
Timing of outcome assessments (detection bias)
Bias because important outcomes were not measured at the same time across groups
There is low risk of bias if all important outcome assessments for all intervention groups were measured at the same time (Van Tulder
2003).
Other bias
Bias due to problems not covered elsewhere in the table
There is a low risk of bias if the study appears to be free of other sources of bias not addressed elsewhere (e.g. study funding).
Appendix 3. Assessment of Clinial Relevance
1. Are the patients described in detail so that you can decide whether they are comparable to those that you see in your practice?
2. Are the interventions and treatment settings described well enough so that you can provide the same for your patients?
3. Were all clinically relevant outcomes measured and reported?
4. Is the size of the effect clinically important?
5. Are the likely treatment benefits worth the potential harms?
WH A T ’ S N E W
Last assessed as up-to-date: 6 March 2012.
Date Event Description
18 December 2012 Amended Amended information for sponsoring of one study (Berg 2009).
C O N T R I B U T I O N S O F A U T H O R S
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Cumhur Oner: Clinical interpretation
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D E C L A R A T I O N S O F I N T E R E S T
None declared.
S O U R C E S O F S U P P O R T
Internal sources
• Sint Maartenskliniek, Netherlands.
Provided allocated time to develop the protocol for the review
• Leiden University Medical Center, Netherlands.
Provided allocated time to perform the review
External sources
• No sources of support supplied
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
It was anticipated during the conception of the protocol that there were fewer than five randomised studies available. This assumption
was based on a recent non-Cochrane review (Van den Eerenbeemt 2010) that included only three studies. According to the BRG
guidelines, with fewer than five studies, non-randomised studies can be included in Cochrane reviews. Our initial methodology was
thus aimed to include non-randomised studies. However, the search resulted in seven RCT’s and only 2 non-randomised, prospective
concurrent controlled studies. The risk of bias in the two small observational studies (Cakir 2006; Schroven 2006) was high. Cakir
2006 et al specifically defined different selection criteria for the two interventions and this consequently resulted in two different groups
with associated distinct age categories. The risk of bias in the observational studies was considered too high to be used alongside the
large randomised controlled trials, or even in addition to these trials. It was therefore decided to omit the poor quality studies from the
analysis. A sensitivity analysis had already been planned between the randomised and non-randomised studies, and this analysis was
now used to assess the effect of omitting these studies. For readability, we have omitted the methodology and results associated with
the aim to include observational studies.
Handling of grey literature and conference proceedings was not described in the protocol. These were excluded and the criterion is
added to the methods section. We decided to exclude conference proceedings because reliable data extraction and risk of bias assessment
from an abstracts is not feasible.
The secondary goals as mentioned in the protocol stem from our previous review. That review deliberately included observational data
on total disc replacement alone for support of some of the secondary questions. Because of the comparative effectiveness and clinical
outcome requirements of this Cochrane version of the review we were unable to validly provide an answer to one secondary question
”What could be considered the indication for total disc replacement of a vertebral motion segment?“. This question requires extensive
epidemiological and prognostic study designs registering extensive patient characteristics.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
Chronic Pain [etiology; ∗surgery]; Intervertebral Disc Degeneration [complications; ∗surgery]; Low Back Pain [etiology; ∗surgery];
Lumbosacral Region; Randomized Controlled Trials as Topic; Spinal Fusion [methods]; Total Disc Replacement [adverse effects;
∗methods]
MeSH check words
Humans
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